BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
876810	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C26H25FN4OS/c27-21-8-10-22(11-9-21)30-17-14-25(28-30)31(26(32)24-7-4-18-33-24)23-12-15-29(16-13-23)19-20-5-2-1-3-6-20/h1-11,14,17-18,23H,12-13,15-16,19H2	TWGDXGQSPFAOIX-UHFFFAOYSA-N	432134	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 1	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432134&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010851	438641075							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876811	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C26H25FN4OS/c27-21-8-10-22(11-9-21)30-17-14-25(28-30)31(26(32)24-7-4-18-33-24)23-12-15-29(16-13-23)19-20-5-2-1-3-6-20/h1-11,14,17-18,23H,12-13,15-16,19H2	TWGDXGQSPFAOIX-UHFFFAOYSA-N	432134	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 1	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432134&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010851	438641075							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876812	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccco1	InChI=1S/C26H25FN4O2/c27-21-8-10-22(11-9-21)30-17-14-25(28-30)31(26(32)24-7-4-18-33-24)23-12-15-29(16-13-23)19-20-5-2-1-3-6-20/h1-11,14,17-18,23H,12-13,15-16,19H2	DZVAMGATOARQCF-UHFFFAOYSA-N	432135	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]furan-2-::US10577360, Example 2	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432135&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585124	438641076							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876813	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccco1	InChI=1S/C26H25FN4O2/c27-21-8-10-22(11-9-21)30-17-14-25(28-30)31(26(32)24-7-4-18-33-24)23-12-15-29(16-13-23)19-20-5-2-1-3-6-20/h1-11,14,17-18,23H,12-13,15-16,19H2	DZVAMGATOARQCF-UHFFFAOYSA-N	432135	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]furan-2-::US10577360, Example 2	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432135&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585124	438641076							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876814	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccno1	InChI=1S/C25H24FN5O2/c26-20-6-8-21(9-7-20)30-17-13-24(28-30)31(25(32)23-10-14-27-33-23)22-11-15-29(16-12-22)18-19-4-2-1-3-5-19/h1-10,13-14,17,22H,11-12,15-16,18H2	VFFSBBRLZBRQMB-UHFFFAOYSA-N	432136	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]isoxazole-5-::US10577360, Example 3	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432136&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036117	438641077							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876815	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccno1	InChI=1S/C25H24FN5O2/c26-20-6-8-21(9-7-20)30-17-13-24(28-30)31(25(32)23-10-14-27-33-23)22-11-15-29(16-12-22)18-19-4-2-1-3-5-19/h1-10,13-14,17,22H,11-12,15-16,18H2	VFFSBBRLZBRQMB-UHFFFAOYSA-N	432136	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]isoxazole-5-::US10577360, Example 3	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432136&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036117	438641077							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876816	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccoc1	InChI=1S/C26H25FN4O2/c27-22-6-8-23(9-7-22)30-16-12-25(28-30)31(26(32)21-13-17-33-19-21)24-10-14-29(15-11-24)18-20-4-2-1-3-5-20/h1-9,12-13,16-17,19,24H,10-11,14-15,18H2	TWSBTVWDDDXBIL-UHFFFAOYSA-N	432137	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]furan-3-::US10577360, Example 4	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432137&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036118	438641078							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876817	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccoc1	InChI=1S/C26H25FN4O2/c27-22-6-8-23(9-7-22)30-16-12-25(28-30)31(26(32)21-13-17-33-19-21)24-10-14-29(15-11-24)18-20-4-2-1-3-5-20/h1-9,12-13,16-17,19,24H,10-11,14-15,18H2	TWSBTVWDDDXBIL-UHFFFAOYSA-N	432137	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]furan-3-::US10577360, Example 4	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432137&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036118	438641078							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876818	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C25H24FN5OS/c26-20-6-8-21(9-7-20)30-16-12-23(28-30)31(25(32)24-27-13-17-33-24)22-10-14-29(15-11-22)18-19-4-2-1-3-5-19/h1-9,12-13,16-17,22H,10-11,14-15,18H2	VXORUWRGDGGEDH-UHFFFAOYSA-N	432138	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]thiazole-2-::US10577360, Example 5	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432138&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585066	438641079							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876819	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C25H24FN5OS/c26-20-6-8-21(9-7-20)30-16-12-23(28-30)31(25(32)24-27-13-17-33-24)22-10-14-29(15-11-22)18-19-4-2-1-3-5-19/h1-9,12-13,16-17,22H,10-11,14-15,18H2	VXORUWRGDGGEDH-UHFFFAOYSA-N	432138	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]thiazole-2-::US10577360, Example 5	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432138&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585066	438641079							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876820	Cn1cccc1C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccc(F)cc1	InChI=1S/C27H28FN5O/c1-30-16-5-8-25(30)27(34)33(26-15-19-32(29-26)23-11-9-22(28)10-12-23)24-13-17-31(18-14-24)20-21-6-3-2-4-7-21/h2-12,15-16,19,24H,13-14,17-18,20H2,1H3	SEEBZMZUETTZFE-UHFFFAOYSA-N	432139	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]-1-methyl-1H-::US10577360, Example 6	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432139&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585134	438641080							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876821	Cn1cccc1C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccc(F)cc1	InChI=1S/C27H28FN5O/c1-30-16-5-8-25(30)27(34)33(26-15-19-32(29-26)23-11-9-22(28)10-12-23)24-13-17-31(18-14-24)20-21-6-3-2-4-7-21/h2-12,15-16,19,24H,13-14,17-18,20H2,1H3	SEEBZMZUETTZFE-UHFFFAOYSA-N	432139	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]-1-methyl-1H-::US10577360, Example 6	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432139&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585134	438641080							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876822	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cnco1	InChI=1S/C25H24FN5O2/c26-20-6-8-21(9-7-20)30-15-12-24(28-30)31(25(32)23-16-27-18-33-23)22-10-13-29(14-11-22)17-19-4-2-1-3-5-19/h1-9,12,15-16,18,22H,10-11,13-14,17H2	GKMOZIFVFGJCFB-UHFFFAOYSA-N	432141	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]oxazole-5-::US10577360, Example 7	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432141&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138605733	438641082							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876823	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cnco1	InChI=1S/C25H24FN5O2/c26-20-6-8-21(9-7-20)30-15-12-24(28-30)31(25(32)23-16-27-18-33-23)22-10-13-29(14-11-22)17-19-4-2-1-3-5-19/h1-9,12,15-16,18,22H,10-11,13-14,17H2	GKMOZIFVFGJCFB-UHFFFAOYSA-N	432141	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1H-pyrazol-3-yl]oxazole-5-::US10577360, Example 7	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432141&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138605733	438641082							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876824	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(CCc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H27FN4OS/c28-22-8-10-23(11-9-22)31-19-15-26(29-31)32(27(33)25-7-4-20-34-25)24-13-17-30(18-14-24)16-12-21-5-2-1-3-6-21/h1-11,15,19-20,24H,12-14,16-18H2	ZVIGPCDDFIZRLB-UHFFFAOYSA-N	432142	N-[1-(4-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-phenethylpiperidin-4-yl)thiophene-2-::US10577360, Example 8	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432142&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585171	438641083							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876825	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(CCc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H27FN4OS/c28-22-8-10-23(11-9-22)31-19-15-26(29-31)32(27(33)25-7-4-20-34-25)24-13-17-30(18-14-24)16-12-21-5-2-1-3-6-21/h1-11,15,19-20,24H,12-14,16-18H2	ZVIGPCDDFIZRLB-UHFFFAOYSA-N	432142	N-[1-(4-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-phenethylpiperidin-4-yl)thiophene-2-::US10577360, Example 8	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432142&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585171	438641083							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876826	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(CCc2ccccc2)CC1)C(=O)c1ccno1	InChI=1S/C26H26FN5O2/c27-21-6-8-22(9-7-21)31-19-14-25(29-31)32(26(33)24-10-15-28-34-24)23-12-17-30(18-13-23)16-11-20-4-2-1-3-5-20/h1-10,14-15,19,23H,11-13,16-18H2	LKTXCICOIKWYLT-UHFFFAOYSA-N	432143	N-[1-(4-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-phenethylpiperidin-4-yl)isoxazole-5-::US10577360, Example 9	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432143&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585155	438641084							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876827	Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(CCc2ccccc2)CC1)C(=O)c1ccno1	InChI=1S/C26H26FN5O2/c27-21-6-8-22(9-7-21)31-19-14-25(29-31)32(26(33)24-10-15-28-34-24)23-12-17-30(18-13-23)16-11-20-4-2-1-3-5-20/h1-10,14-15,19,23H,11-13,16-18H2	LKTXCICOIKWYLT-UHFFFAOYSA-N	432143	N-[1-(4-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-phenethylpiperidin-4-yl)isoxazole-5-::US10577360, Example 9	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432143&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585155	438641084							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876828	Fc1ccc(cc1)-c1cnc(cn1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H25FN4OS/c28-22-10-8-21(9-11-22)24-17-30-26(18-29-24)32(27(33)25-7-4-16-34-25)23-12-14-31(15-13-23)19-20-5-2-1-3-6-20/h1-11,16-18,23H,12-15,19H2	NIVJEARPFGXFDD-UHFFFAOYSA-N	432144	N-(1-Benzylpiperidin-4-yl)-N-[5-(4-fluorophenyl)pyrazin-2-yl]thiophene-2-::US10577360, Example 10	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432144&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036122	438641085							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876829	Fc1ccc(cc1)-c1cnc(cn1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H25FN4OS/c28-22-10-8-21(9-11-22)24-17-30-26(18-29-24)32(27(33)25-7-4-16-34-25)23-12-14-31(15-13-23)19-20-5-2-1-3-6-20/h1-11,16-18,23H,12-15,19H2	NIVJEARPFGXFDD-UHFFFAOYSA-N	432144	N-(1-Benzylpiperidin-4-yl)-N-[5-(4-fluorophenyl)pyrazin-2-yl]thiophene-2-::US10577360, Example 10	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432144&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036122	438641085							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876830	Fc1ccc(cc1)-c1cncc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H25FN4OS/c28-22-10-8-21(9-11-22)24-17-29-18-26(30-24)32(27(33)25-7-4-16-34-25)23-12-14-31(15-13-23)19-20-5-2-1-3-6-20/h1-11,16-18,23H,12-15,19H2	POEGPHFIBDFUTG-UHFFFAOYSA-N	432145	N-(1-Benzylpiperidin-4-yl)-N-[6-(4-fluorophenyl)pyrazin-2-yl]thiophene-2-::US10577360, Example 11	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432145&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036125	438641086							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876831	Fc1ccc(cc1)-c1cncc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H25FN4OS/c28-22-10-8-21(9-11-22)24-17-29-18-26(30-24)32(27(33)25-7-4-16-34-25)23-12-14-31(15-13-23)19-20-5-2-1-3-6-20/h1-11,16-18,23H,12-15,19H2	POEGPHFIBDFUTG-UHFFFAOYSA-N	432145	N-(1-Benzylpiperidin-4-yl)-N-[6-(4-fluorophenyl)pyrazin-2-yl]thiophene-2-::US10577360, Example 11	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432145&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036125	438641086							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876832	O=C(N(C1CCN(Cc2ccccc2)CC1)c1cncc(n1)-c1ccccc1)c1cccs1	InChI=1S/C27H26N4OS/c32-27(25-12-7-17-33-25)31(26-19-28-18-24(29-26)22-10-5-2-6-11-22)23-13-15-30(16-14-23)20-21-8-3-1-4-9-21/h1-12,17-19,23H,13-16,20H2	YAFSJVRDFZMWRN-UHFFFAOYSA-N	432146	N-(1-Benzylpiperidin-4-yl)-N-(6-phenylpyrazin-2-yl)thiophene-2-carboxamide::US10577360, Example 12	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432146&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036124	438641087							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876833	O=C(N(C1CCN(Cc2ccccc2)CC1)c1cncc(n1)-c1ccccc1)c1cccs1	InChI=1S/C27H26N4OS/c32-27(25-12-7-17-33-25)31(26-19-28-18-24(29-26)22-10-5-2-6-11-22)23-13-15-30(16-14-23)20-21-8-3-1-4-9-21/h1-12,17-19,23H,13-16,20H2	YAFSJVRDFZMWRN-UHFFFAOYSA-N	432146	N-(1-Benzylpiperidin-4-yl)-N-(6-phenylpyrazin-2-yl)thiophene-2-carboxamide::US10577360, Example 12	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432146&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036124	438641087							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876834	CCOc1ccc(cc1)-c1cncc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C29H30N4O2S/c1-2-35-25-12-10-23(11-13-25)26-19-30-20-28(31-26)33(29(34)27-9-6-18-36-27)24-14-16-32(17-15-24)21-22-7-4-3-5-8-22/h3-13,18-20,24H,2,14-17,21H2,1H3	IMYDUSLZCPMLQL-UHFFFAOYSA-N	432147	N-(1-Benzylpiperidin-4-yl)-N-[6-(4-ethoxyphenyl)pyrazin-2-yl]thiophene-2-::US10577360, Example 13	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432147&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036123	438641088							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876835	CCOc1ccc(cc1)-c1cncc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C29H30N4O2S/c1-2-35-25-12-10-23(11-13-25)26-19-30-20-28(31-26)33(29(34)27-9-6-18-36-27)24-14-16-32(17-15-24)21-22-7-4-3-5-8-22/h3-13,18-20,24H,2,14-17,21H2,1H3	IMYDUSLZCPMLQL-UHFFFAOYSA-N	432147	N-(1-Benzylpiperidin-4-yl)-N-[6-(4-ethoxyphenyl)pyrazin-2-yl]thiophene-2-::US10577360, Example 13	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432147&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036123	438641088							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876836	CCOc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C28H30N4O2S/c1-2-34-25-12-10-23(11-13-25)31-19-16-27(29-31)32(28(33)26-9-6-20-35-26)24-14-17-30(18-15-24)21-22-7-4-3-5-8-22/h3-13,16,19-20,24H,2,14-15,17-18,21H2,1H3	NCOZCAABANAFFF-UHFFFAOYSA-N	432148	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-ethoxyphenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 14	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432148&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036126	438641089							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876837	CCOc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C28H30N4O2S/c1-2-34-25-12-10-23(11-13-25)31-19-16-27(29-31)32(28(33)26-9-6-20-35-26)24-14-17-30(18-15-24)21-22-7-4-3-5-8-22/h3-13,16,19-20,24H,2,14-15,17-18,21H2,1H3	NCOZCAABANAFFF-UHFFFAOYSA-N	432148	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-ethoxyphenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 14	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432148&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036126	438641089							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876838	CCOc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C27H29N5O2S/c1-2-34-24-10-8-22(9-11-24)31-18-14-25(29-31)32(27(33)26-28-15-19-35-26)23-12-16-30(17-13-23)20-21-6-4-3-5-7-21/h3-11,14-15,18-19,23H,2,12-13,16-17,20H2,1H3	WFFVUAAEZGJCTK-UHFFFAOYSA-N	432149	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-ethoxyphenyl)-1H-pyrazol-3-yl]thiazole-2-::US10577360, Example 15	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432149&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035990	438641090							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876839	CCOc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C27H29N5O2S/c1-2-34-24-10-8-22(9-11-24)31-18-14-25(29-31)32(27(33)26-28-15-19-35-26)23-12-16-30(17-13-23)20-21-6-4-3-5-7-21/h3-11,14-15,18-19,23H,2,12-13,16-17,20H2,1H3	WFFVUAAEZGJCTK-UHFFFAOYSA-N	432149	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-ethoxyphenyl)-1H-pyrazol-3-yl]thiazole-2-::US10577360, Example 15	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432149&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035990	438641090							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876840	O=C(N(C1CCN(CCc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C27H28N4OS/c32-27(25-12-7-21-33-25)31(26-16-20-30(28-26)23-10-5-2-6-11-23)24-14-18-29(19-15-24)17-13-22-8-3-1-4-9-22/h1-12,16,20-21,24H,13-15,17-19H2	KONNMDLTTAUDPS-UHFFFAOYSA-N	432150	N-(1-Phenethylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl) thiophene-2-::US10577360, Example 16	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432150&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035986	438641091							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876841	O=C(N(C1CCN(CCc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C27H28N4OS/c32-27(25-12-7-21-33-25)31(26-16-20-30(28-26)23-10-5-2-6-11-23)24-14-18-29(19-15-24)17-13-22-8-3-1-4-9-22/h1-12,16,20-21,24H,13-15,17-19H2	KONNMDLTTAUDPS-UHFFFAOYSA-N	432150	N-(1-Phenethylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl) thiophene-2-::US10577360, Example 16	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432150&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035986	438641091							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876842	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C26H26N4OS/c31-26(24-12-7-19-32-24)30(25-15-18-29(27-25)22-10-5-2-6-11-22)23-13-16-28(17-14-23)20-21-8-3-1-4-9-21/h1-12,15,18-19,23H,13-14,16-17,20H2	BLMVWABUNKDISI-UHFFFAOYSA-N	432151	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 17	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432151&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035993	438641092							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876843	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C26H26N4OS/c31-26(24-12-7-19-32-24)30(25-15-18-29(27-25)22-10-5-2-6-11-22)23-13-16-28(17-14-23)20-21-8-3-1-4-9-21/h1-12,15,18-19,23H,13-14,16-17,20H2	BLMVWABUNKDISI-UHFFFAOYSA-N	432151	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 17	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432151&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035993	438641092							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876844	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1ccco1	InChI=1S/C26H26N4O2/c31-26(24-12-7-19-32-24)30(25-15-18-29(27-25)22-10-5-2-6-11-22)23-13-16-28(17-14-23)20-21-8-3-1-4-9-21/h1-12,15,18-19,23H,13-14,16-17,20H2	KPPOQNYOCQXZOS-UHFFFAOYSA-N	432152	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)furan-2-carboxamide::US10577360, Example 18	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432152&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584836	438641093							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876845	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1ccco1	InChI=1S/C26H26N4O2/c31-26(24-12-7-19-32-24)30(25-15-18-29(27-25)22-10-5-2-6-11-22)23-13-16-28(17-14-23)20-21-8-3-1-4-9-21/h1-12,15,18-19,23H,13-14,16-17,20H2	KPPOQNYOCQXZOS-UHFFFAOYSA-N	432152	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)furan-2-carboxamide::US10577360, Example 18	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432152&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584836	438641093							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876846	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1nccs1	InChI=1S/C25H25N5OS/c31-25(24-26-14-18-32-24)30(23-13-17-29(27-23)21-9-5-2-6-10-21)22-11-15-28(16-12-22)19-20-7-3-1-4-8-20/h1-10,13-14,17-18,22H,11-12,15-16,19H2	JZUCRUQJISJWIM-UHFFFAOYSA-N	432153	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiazole-2-carboxamide::US10577360, Example 19	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432153&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035987	438641094							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876847	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1nccs1	InChI=1S/C25H25N5OS/c31-25(24-26-14-18-32-24)30(23-13-17-29(27-23)21-9-5-2-6-10-21)22-11-15-28(16-12-22)19-20-7-3-1-4-8-20/h1-10,13-14,17-18,22H,11-12,15-16,19H2	JZUCRUQJISJWIM-UHFFFAOYSA-N	432153	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiazole-2-carboxamide::US10577360, Example 19	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432153&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035987	438641094							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876848	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1ccccn1	InChI=1S/C27H27N5O/c33-27(25-13-7-8-17-28-25)32(26-16-20-31(29-26)23-11-5-2-6-12-23)24-14-18-30(19-15-24)21-22-9-3-1-4-10-22/h1-13,16-17,20,24H,14-15,18-19,21H2	PHFPDZCKZVLUPG-UHFFFAOYSA-N	432154	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)picolinamide::US10577360, Example 20	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432154&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585181	438641095							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876849	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1ccccn1	InChI=1S/C27H27N5O/c33-27(25-13-7-8-17-28-25)32(26-16-20-31(29-26)23-11-5-2-6-12-23)24-14-18-30(19-15-24)21-22-9-3-1-4-10-22/h1-13,16-17,20,24H,14-15,18-19,21H2	PHFPDZCKZVLUPG-UHFFFAOYSA-N	432154	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)picolinamide::US10577360, Example 20	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432154&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585181	438641095							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876850	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1cncs1	InChI=1S/C25H25N5OS/c31-25(23-17-26-19-32-23)30(24-13-16-29(27-24)21-9-5-2-6-10-21)22-11-14-28(15-12-22)18-20-7-3-1-4-8-20/h1-10,13,16-17,19,22H,11-12,14-15,18H2	YSBIHZNLABOJQI-UHFFFAOYSA-N	432155	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiazole-5-carboxamide::US10577360, Example 21	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432155&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035994	438641096							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876851	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1cncs1	InChI=1S/C25H25N5OS/c31-25(23-17-26-19-32-23)30(24-13-16-29(27-24)21-9-5-2-6-10-21)22-11-14-28(15-12-22)18-20-7-3-1-4-8-20/h1-10,13,16-17,19,22H,11-12,14-15,18H2	YSBIHZNLABOJQI-UHFFFAOYSA-N	432155	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiazole-5-carboxamide::US10577360, Example 21	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432155&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035994	438641096							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876852	Fc1ccc(s1)C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C26H25FN4OS/c27-24-12-11-23(33-24)26(32)31(25-15-18-30(28-25)21-9-5-2-6-10-21)22-13-16-29(17-14-22)19-20-7-3-1-4-8-20/h1-12,15,18,22H,13-14,16-17,19H2	VTEFMBSYBDGIAF-UHFFFAOYSA-N	432156	N-(1-Benzylpiperidin-4-yl)-5-fluoro-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 22	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432156&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584975	438641097							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876853	Fc1ccc(s1)C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C26H25FN4OS/c27-24-12-11-23(33-24)26(32)31(25-15-18-30(28-25)21-9-5-2-6-10-21)22-13-16-29(17-14-22)19-20-7-3-1-4-8-20/h1-12,15,18,22H,13-14,16-17,19H2	VTEFMBSYBDGIAF-UHFFFAOYSA-N	432156	N-(1-Benzylpiperidin-4-yl)-5-fluoro-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 22	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432156&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584975	438641097							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876854	Clc1ccc(s1)C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C26H25ClN4OS/c27-24-12-11-23(33-24)26(32)31(25-15-18-30(28-25)21-9-5-2-6-10-21)22-13-16-29(17-14-22)19-20-7-3-1-4-8-20/h1-12,15,18,22H,13-14,16-17,19H2	KCFATVFDJGUCIV-UHFFFAOYSA-N	432157	N-(1-Benzylpiperidin-4-yl)-5-chloro-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 23	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432157&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035998	438641098							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876855	Clc1ccc(s1)C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C26H25ClN4OS/c27-24-12-11-23(33-24)26(32)31(25-15-18-30(28-25)21-9-5-2-6-10-21)22-13-16-29(17-14-22)19-20-7-3-1-4-8-20/h1-12,15,18,22H,13-14,16-17,19H2	KCFATVFDJGUCIV-UHFFFAOYSA-N	432157	N-(1-Benzylpiperidin-4-yl)-5-chloro-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 23	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432157&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035998	438641098							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876856	Clc1ccsc1C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C26H25ClN4OS/c27-23-14-18-33-25(23)26(32)31(24-13-17-30(28-24)21-9-5-2-6-10-21)22-11-15-29(16-12-22)19-20-7-3-1-4-8-20/h1-10,13-14,17-18,22H,11-12,15-16,19H2	XOBHPPOXRJVQQK-UHFFFAOYSA-N	432158	N-(1-Benzylpiperidin-4-yl)-3-chloro-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 24	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432158&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035999	438641099							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876857	Clc1ccsc1C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C26H25ClN4OS/c27-23-14-18-33-25(23)26(32)31(24-13-17-30(28-24)21-9-5-2-6-10-21)22-11-15-29(16-12-22)19-20-7-3-1-4-8-20/h1-10,13-14,17-18,22H,11-12,15-16,19H2	XOBHPPOXRJVQQK-UHFFFAOYSA-N	432158	N-(1-Benzylpiperidin-4-yl)-3-chloro-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 24	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432158&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035999	438641099							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876858	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1ccns1	InChI=1S/C25H25N5OS/c31-25(23-11-15-26-32-23)30(24-14-18-29(27-24)21-9-5-2-6-10-21)22-12-16-28(17-13-22)19-20-7-3-1-4-8-20/h1-11,14-15,18,22H,12-13,16-17,19H2	KHBFFIQQTAWLQV-UHFFFAOYSA-N	432159	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)isothiazole-5-carboxamide::US10577360, Example 25	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432159&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036132	438641100							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876859	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1)c1ccns1	InChI=1S/C25H25N5OS/c31-25(23-11-15-26-32-23)30(24-14-18-29(27-24)21-9-5-2-6-10-21)22-12-16-28(17-13-22)19-20-7-3-1-4-8-20/h1-11,14-15,18,22H,12-13,16-17,19H2	KHBFFIQQTAWLQV-UHFFFAOYSA-N	432159	N-(1-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)isothiazole-5-carboxamide::US10577360, Example 25	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432159&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036132	438641100							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876860	COc1ccc(cc1)C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C29H30N4O2/c1-35-27-14-12-24(13-15-27)29(34)33(28-18-21-32(30-28)25-10-6-3-7-11-25)26-16-19-31(20-17-26)22-23-8-4-2-5-9-23/h2-15,18,21,26H,16-17,19-20,22H2,1H3	RGCZXFRWWBZGPI-UHFFFAOYSA-N	432160	N-(1-Benzylpiperidin-4-yl)-4-methoxy-N-(1-phenyl-1H-pyrazol-3-yl)benzamide::US10577360, Example 26	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432160&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036134	438641101							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876861	COc1ccc(cc1)C(=O)N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C29H30N4O2/c1-35-27-14-12-24(13-15-27)29(34)33(28-18-21-32(30-28)25-10-6-3-7-11-25)26-16-19-31(20-17-26)22-23-8-4-2-5-9-23/h2-15,18,21,26H,16-17,19-20,22H2,1H3	RGCZXFRWWBZGPI-UHFFFAOYSA-N	432160	N-(1-Benzylpiperidin-4-yl)-4-methoxy-N-(1-phenyl-1H-pyrazol-3-yl)benzamide::US10577360, Example 26	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432160&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036134	438641101							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876862	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H22N4OS/c1-22-12-9-17(10-13-22)24(20(25)18-8-5-15-26-18)19-11-14-23(21-19)16-6-3-2-4-7-16/h2-8,11,14-15,17H,9-10,12-13H2,1H3	NBFFFSSWIDRREJ-UHFFFAOYSA-N	432161	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 27	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432161&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585133	438641102							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876863	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H22N4OS/c1-22-12-9-17(10-13-22)24(20(25)18-8-5-15-26-18)19-11-14-23(21-19)16-6-3-2-4-7-16/h2-8,11,14-15,17H,9-10,12-13H2,1H3	NBFFFSSWIDRREJ-UHFFFAOYSA-N	432161	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 27	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432161&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585133	438641102							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876864	COc1cccc(c1)C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C23H26N4O2/c1-25-14-11-20(12-15-25)27(23(28)18-7-6-10-21(17-18)29-2)22-13-16-26(24-22)19-8-4-3-5-9-19/h3-10,13,16-17,20H,11-12,14-15H2,1-2H3	RYVBLUTUJMPZMI-UHFFFAOYSA-N	432162	3-Methoxy-N-(1-methyl-piperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)-benzamide::US10577360, Example 28	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432162&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585137	438641103							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876865	COc1cccc(c1)C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C23H26N4O2/c1-25-14-11-20(12-15-25)27(23(28)18-7-6-10-21(17-18)29-2)22-13-16-26(24-22)19-8-4-3-5-9-19/h3-10,13,16-17,20H,11-12,14-15H2,1-2H3	RYVBLUTUJMPZMI-UHFFFAOYSA-N	432162	3-Methoxy-N-(1-methyl-piperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)-benzamide::US10577360, Example 28	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432162&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585137	438641103							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876866	CN1CCC(CC1)N(C(=O)c1cccc(c1)-c1nnc(C)o1)c1ccn(n1)-c1ccccc1	InChI=1S/C25H26N6O2/c1-18-26-27-24(33-18)19-7-6-8-20(17-19)25(32)31(22-11-14-29(2)15-12-22)23-13-16-30(28-23)21-9-4-3-5-10-21/h3-10,13,16-17,22H,11-12,14-15H2,1-2H3	BSQJNINZGDYBHE-UHFFFAOYSA-N	432163	3-(5-Methyl-[1,3,4]oxadiazol-2-yl)-N-(1-methyl-piperidin-4-yl)-N-(1-phenyl-1H-::US10577360, Example 29	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432163&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584879	438641104							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876867	CN1CCC(CC1)N(C(=O)c1cccc(c1)-c1nnc(C)o1)c1ccn(n1)-c1ccccc1	InChI=1S/C25H26N6O2/c1-18-26-27-24(33-18)19-7-6-8-20(17-19)25(32)31(22-11-14-29(2)15-12-22)23-13-16-30(28-23)21-9-4-3-5-10-21/h3-10,13,16-17,22H,11-12,14-15H2,1-2H3	BSQJNINZGDYBHE-UHFFFAOYSA-N	432163	3-(5-Methyl-[1,3,4]oxadiazol-2-yl)-N-(1-methyl-piperidin-4-yl)-N-(1-phenyl-1H-::US10577360, Example 29	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432163&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584879	438641104							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876868	CN1CCC(CC1)N(C(=O)c1ccccc1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H24N4O/c1-24-15-12-20(13-16-24)26(22(27)18-8-4-2-5-9-18)21-14-17-25(23-21)19-10-6-3-7-11-19/h2-11,14,17,20H,12-13,15-16H2,1H3	BWDHMJHGTZIXNN-UHFFFAOYSA-N	432164	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)benzamide::US10577360, Example 30	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432164&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036145	438641105							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876869	CN1CCC(CC1)N(C(=O)c1ccccc1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H24N4O/c1-24-15-12-20(13-16-24)26(22(27)18-8-4-2-5-9-18)21-14-17-25(23-21)19-10-6-3-7-11-19/h2-11,14,17,20H,12-13,15-16H2,1H3	BWDHMJHGTZIXNN-UHFFFAOYSA-N	432164	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)benzamide::US10577360, Example 30	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432164&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036145	438641105							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876870	COc1ccccc1C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C23H26N4O2/c1-25-15-12-19(13-16-25)27(23(28)20-10-6-7-11-21(20)29-2)22-14-17-26(24-22)18-8-4-3-5-9-18/h3-11,14,17,19H,12-13,15-16H2,1-2H3	SSZZAXXOOPSVGS-UHFFFAOYSA-N	432165	2-Methoxy-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)benzamide::US10577360, Example 31	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432165&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585121	438641106							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876871	COc1ccccc1C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1ccccc1	InChI=1S/C23H26N4O2/c1-25-15-12-19(13-16-25)27(23(28)20-10-6-7-11-21(20)29-2)22-14-17-26(24-22)18-8-4-3-5-9-18/h3-11,14,17,19H,12-13,15-16H2,1-2H3	SSZZAXXOOPSVGS-UHFFFAOYSA-N	432165	2-Methoxy-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)benzamide::US10577360, Example 31	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432165&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585121	438641106							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876872	CN1CCC(CC1)N(C(=O)c1ncccc1F)c1ccn(n1)-c1ccccc1	InChI=1S/C21H22FN5O/c1-25-13-9-17(10-14-25)27(21(28)20-18(22)8-5-12-23-20)19-11-15-26(24-19)16-6-3-2-4-7-16/h2-8,11-12,15,17H,9-10,13-14H2,1H3	UXRPACNWCOYRSZ-UHFFFAOYSA-N	432166	3-Fluoro-N-(1-methylpiperidin-4-yl)-N-1-phenyl-1H-pyrazol-3-yl)picolinamide::US10577360, Example 32	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432166&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036142	438641107							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876873	CN1CCC(CC1)N(C(=O)c1ncccc1F)c1ccn(n1)-c1ccccc1	InChI=1S/C21H22FN5O/c1-25-13-9-17(10-14-25)27(21(28)20-18(22)8-5-12-23-20)19-11-15-26(24-19)16-6-3-2-4-7-16/h2-8,11-12,15,17H,9-10,13-14H2,1H3	UXRPACNWCOYRSZ-UHFFFAOYSA-N	432166	3-Fluoro-N-(1-methylpiperidin-4-yl)-N-1-phenyl-1H-pyrazol-3-yl)picolinamide::US10577360, Example 32	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432166&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036142	438641107							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876874	CN1CCC(CC1)N(C(=O)c1cccnc1)c1ccn(n1)-c1ccccc1	InChI=1S/C21H23N5O/c1-24-13-9-19(10-14-24)26(21(27)17-6-5-12-22-16-17)20-11-15-25(23-20)18-7-3-2-4-8-18/h2-8,11-12,15-16,19H,9-10,13-14H2,1H3	JWRHZXPYHNZILZ-UHFFFAOYSA-N	432167	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)nicotinamide::US10577360, Example 33	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432167&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584948	438641108							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876875	CN1CCC(CC1)N(C(=O)c1cccnc1)c1ccn(n1)-c1ccccc1	InChI=1S/C21H23N5O/c1-24-13-9-19(10-14-24)26(21(27)17-6-5-12-22-16-17)20-11-15-25(23-20)18-7-3-2-4-8-18/h2-8,11-12,15-16,19H,9-10,13-14H2,1H3	JWRHZXPYHNZILZ-UHFFFAOYSA-N	432167	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)nicotinamide::US10577360, Example 33	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432167&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584948	438641108							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876876	CN1CCC(CC1)N(C(=O)c1c(C)cccc1F)c1ccn(n1)-c1ccccc1	InChI=1S/C23H25FN4O/c1-17-7-6-10-20(24)22(17)23(29)28(19-11-14-26(2)15-12-19)21-13-16-27(25-21)18-8-4-3-5-9-18/h3-10,13,16,19H,11-12,14-15H2,1-2H3	RJSGPZSKQZVFFC-UHFFFAOYSA-N	432168	2-Fluoro-6-methyl-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-::US10577360, Example 34	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432168&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584923	438641109							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876877	CN1CCC(CC1)N(C(=O)c1c(C)cccc1F)c1ccn(n1)-c1ccccc1	InChI=1S/C23H25FN4O/c1-17-7-6-10-20(24)22(17)23(29)28(19-11-14-26(2)15-12-19)21-13-16-27(25-21)18-8-4-3-5-9-18/h3-10,13,16,19H,11-12,14-15H2,1-2H3	RJSGPZSKQZVFFC-UHFFFAOYSA-N	432168	2-Fluoro-6-methyl-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-::US10577360, Example 34	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432168&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584923	438641109							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876878	CN1CCC(CC1)N(C(=O)c1nc(C)cs1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H23N5OS/c1-15-14-27-19(21-15)20(26)25(17-8-11-23(2)12-9-17)18-10-13-24(22-18)16-6-4-3-5-7-16/h3-7,10,13-14,17H,8-9,11-12H2,1-2H3	FVKXQEVCVVUPSQ-UHFFFAOYSA-N	432169	4-Methyl-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiazole-2-::US10577360, Example 35	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432169&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585148	438641110							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876879	CN1CCC(CC1)N(C(=O)c1nc(C)cs1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H23N5OS/c1-15-14-27-19(21-15)20(26)25(17-8-11-23(2)12-9-17)18-10-13-24(22-18)16-6-4-3-5-7-16/h3-7,10,13-14,17H,8-9,11-12H2,1-2H3	FVKXQEVCVVUPSQ-UHFFFAOYSA-N	432169	4-Methyl-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiazole-2-::US10577360, Example 35	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432169&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585148	438641110							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876880	CN1CCC(CC1)N(C(=O)c1ccc(C)nc1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H25N5O/c1-17-8-9-18(16-23-17)22(28)27(20-10-13-25(2)14-11-20)21-12-15-26(24-21)19-6-4-3-5-7-19/h3-9,12,15-16,20H,10-11,13-14H2,1-2H3	QLKYGYGAYURFKP-UHFFFAOYSA-N	432170	6-Methyl-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)nicotinamide::US10577360, Example 36	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432170&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584981	438641111							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876881	CN1CCC(CC1)N(C(=O)c1ccc(C)nc1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H25N5O/c1-17-8-9-18(16-23-17)22(28)27(20-10-13-25(2)14-11-20)21-12-15-26(24-21)19-6-4-3-5-7-19/h3-9,12,15-16,20H,10-11,13-14H2,1-2H3	QLKYGYGAYURFKP-UHFFFAOYSA-N	432170	6-Methyl-N-(1-methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)nicotinamide::US10577360, Example 36	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432170&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584981	438641111							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876882	CN1CCC(CC1)N(C(=O)c1ccc[nH]1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H23N5O/c1-23-13-9-17(10-14-23)25(20(26)18-8-5-12-21-18)19-11-15-24(22-19)16-6-3-2-4-7-16/h2-8,11-12,15,17,21H,9-10,13-14H2,1H3	ONPDPPTZCUEMFK-UHFFFAOYSA-N	432171	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide::US10577360, Example 37	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432171&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036007	438641112							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876883	CN1CCC(CC1)N(C(=O)c1ccc[nH]1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H23N5O/c1-23-13-9-17(10-14-23)25(20(26)18-8-5-12-21-18)19-11-15-24(22-19)16-6-3-2-4-7-16/h2-8,11-12,15,17,21H,9-10,13-14H2,1H3	ONPDPPTZCUEMFK-UHFFFAOYSA-N	432171	N-(1-Methylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide::US10577360, Example 37	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432171&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036007	438641112							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876884	CN1CCCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C21H24N4OS/c1-23-13-5-9-18(11-14-23)25(21(26)19-10-6-16-27-19)20-12-15-24(22-20)17-7-3-2-4-8-17/h2-4,6-8,10,12,15-16,18H,5,9,11,13-14H2,1H3	VVTLURVNJMUVEN-UHFFFAOYSA-N	432172	N-(1-Methylazepan-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 39	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432172&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036009	438641113							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876885	CN1CCCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C21H24N4OS/c1-23-13-5-9-18(11-14-23)25(21(26)19-10-6-16-27-19)20-12-15-24(22-20)17-7-3-2-4-8-17/h2-4,6-8,10,12,15-16,18H,5,9,11,13-14H2,1H3	VVTLURVNJMUVEN-UHFFFAOYSA-N	432172	N-(1-Methylazepan-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 39	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432172&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036009	438641113							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876886	CC1CC(CC(C)N1Cc1ccccc1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C28H30N4OS/c1-21-18-25(19-22(2)30(21)20-23-10-5-3-6-11-23)32(28(33)26-14-9-17-34-26)27-15-16-31(29-27)24-12-7-4-8-13-24/h3-17,21-22,25H,18-20H2,1-2H3	JYDFKHYWCQKAMH-UHFFFAOYSA-N	432173	N-(1-Benzyl-2,6-dimethylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 40	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432173&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035879	438641114							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876887	CC1CC(CC(C)N1Cc1ccccc1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C28H30N4OS/c1-21-18-25(19-22(2)30(21)20-23-10-5-3-6-11-23)32(28(33)26-14-9-17-34-26)27-15-16-31(29-27)24-12-7-4-8-13-24/h3-17,21-22,25H,18-20H2,1-2H3	JYDFKHYWCQKAMH-UHFFFAOYSA-N	432173	N-(1-Benzyl-2,6-dimethylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 40	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432173&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035879	438641114							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876888	CC1CC(CC(C)N1C)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H26N4OS/c1-16-14-19(15-17(2)24(16)3)26(22(27)20-10-7-13-28-20)21-11-12-25(23-21)18-8-5-4-6-9-18/h4-13,16-17,19H,14-15H2,1-3H3	BXCYECWKRCTJIT-UHFFFAOYSA-N	432177	N-(1-Phenyl-1H-pyrazol-3-yl)-N-(1,2,6-trimethylpiperidin-4-yl)thiophene-2-::US10577360, Example 41	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432177&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035878	438641117							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876889	CC1CC(CC(C)N1C)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H26N4OS/c1-16-14-19(15-17(2)24(16)3)26(22(27)20-10-7-13-28-20)21-11-12-25(23-21)18-8-5-4-6-9-18/h4-13,16-17,19H,14-15H2,1-3H3	BXCYECWKRCTJIT-UHFFFAOYSA-N	432177	N-(1-Phenyl-1H-pyrazol-3-yl)-N-(1,2,6-trimethylpiperidin-4-yl)thiophene-2-::US10577360, Example 41	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432177&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035878	438641117							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876890	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C28H27N7O2S/c1-20-30-31-26(37-20)22-8-5-9-24(18-22)34-16-12-25(32-34)35(28(36)27-29-13-17-38-27)23-10-14-33(15-11-23)19-21-6-3-2-4-7-21/h2-9,12-13,16-18,23H,10-11,14-15,19H2,1H3	LKMAZENQDJPAOZ-UHFFFAOYSA-N	432179	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 43	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432179&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584985	438641119							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876891	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C28H27N7O2S/c1-20-30-31-26(37-20)22-8-5-9-24(18-22)34-16-12-25(32-34)35(28(36)27-29-13-17-38-27)23-10-14-33(15-11-23)19-21-6-3-2-4-7-21/h2-9,12-13,16-18,23H,10-11,14-15,19H2,1H3	LKMAZENQDJPAOZ-UHFFFAOYSA-N	432179	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 43	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432179	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432179&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584985	438641119							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876892	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccns1	InChI=1S/C28H27N7O2S/c1-20-30-31-27(37-20)22-8-5-9-24(18-22)34-17-13-26(32-34)35(28(36)25-10-14-29-38-25)23-11-15-33(16-12-23)19-21-6-3-2-4-7-21/h2-10,13-14,17-18,23H,11-12,15-16,19H2,1H3	GRTSKBCCFGRZHS-UHFFFAOYSA-N	432180	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 44	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432180&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584988	438641120							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876893	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccns1	InChI=1S/C28H27N7O2S/c1-20-30-31-27(37-20)22-8-5-9-24(18-22)34-17-13-26(32-34)35(28(36)25-10-14-29-38-25)23-11-15-33(16-12-23)19-21-6-3-2-4-7-21/h2-10,13-14,17-18,23H,11-12,15-16,19H2,1H3	GRTSKBCCFGRZHS-UHFFFAOYSA-N	432180	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 44	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432180&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584988	438641120							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876894	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(CCc2ccccn2)CC1)C(=O)c1cccs1	InChI=1S/C29H29N7O2S/c1-21-31-32-28(38-21)22-6-4-8-25(20-22)35-18-13-27(33-35)36(29(37)26-9-5-19-39-26)24-11-16-34(17-12-24)15-10-23-7-2-3-14-30-23/h2-9,13-14,18-20,24H,10-12,15-17H2,1H3	RBIQKWJKCKSOJQ-UHFFFAOYSA-N	432181	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-{1-[2-pyridin-2-::US10577360, Example 45	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432181&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035890	438641121							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876895	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(CCc2ccccn2)CC1)C(=O)c1cccs1	InChI=1S/C29H29N7O2S/c1-21-31-32-28(38-21)22-6-4-8-25(20-22)35-18-13-27(33-35)36(29(37)26-9-5-19-39-26)24-11-16-34(17-12-24)15-10-23-7-2-3-14-30-23/h2-9,13-14,18-20,24H,10-12,15-17H2,1H3	RBIQKWJKCKSOJQ-UHFFFAOYSA-N	432181	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-{1-[2-pyridin-2-::US10577360, Example 45	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432181&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035890	438641121							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876896	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2cccnc2)CC1)C(=O)c1cccs1	InChI=1S/C26H27N5O2S/c1-33-23-7-2-6-22(17-23)30-15-11-25(28-30)31(26(32)24-8-4-16-34-24)21-9-13-29(14-10-21)19-20-5-3-12-27-18-20/h2-8,11-12,15-18,21H,9-10,13-14,19H2,1H3	YPKYXOULCQHNGQ-UHFFFAOYSA-N	432182	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-(pyridin-3-ylmethyl)piperidin-4-::US10577360, Example 46	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432182&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035895	438641122							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876897	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2cccnc2)CC1)C(=O)c1cccs1	InChI=1S/C26H27N5O2S/c1-33-23-7-2-6-22(17-23)30-15-11-25(28-30)31(26(32)24-8-4-16-34-24)21-9-13-29(14-10-21)19-20-5-3-12-27-18-20/h2-8,11-12,15-18,21H,9-10,13-14,19H2,1H3	YPKYXOULCQHNGQ-UHFFFAOYSA-N	432182	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-(pyridin-3-ylmethyl)piperidin-4-::US10577360, Example 46	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432182&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035895	438641122							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876898	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ncn(n1)-c1ccccc1)c1cccs1	InChI=1S/C25H25N5OS/c31-24(23-12-7-17-32-23)30(25-26-19-29(27-25)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	CKITXGOQMOYVPA-UHFFFAOYSA-N	432183	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,4-triazol-3-yl)thiophene-2-::US10577360, Example 47	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432183&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035899	438641123							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876899	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ncn(n1)-c1ccccc1)c1cccs1	InChI=1S/C25H25N5OS/c31-24(23-12-7-17-32-23)30(25-26-19-29(27-25)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	CKITXGOQMOYVPA-UHFFFAOYSA-N	432183	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,4-triazol-3-yl)thiophene-2-::US10577360, Example 47	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432183&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035899	438641123							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876900	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ncn(n1)-c1ccccc1)c1ccco1	InChI=1S/C25H25N5O2/c31-24(23-12-7-17-32-23)30(25-26-19-29(27-25)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	DGMYZIPWWVBDJT-UHFFFAOYSA-N	432184	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,4-triazol-3-yl)furan-2-carboxamide::US10577360, Example 48	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432184&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035900	438641124							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876901	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ncn(n1)-c1ccccc1)c1ccco1	InChI=1S/C25H25N5O2/c31-24(23-12-7-17-32-23)30(25-26-19-29(27-25)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	DGMYZIPWWVBDJT-UHFFFAOYSA-N	432184	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,4-triazol-3-yl)furan-2-carboxamide::US10577360, Example 48	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432184&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035900	438641124							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876902	O=C(N(C1CCN(CCc2ccccc2)CC1)c1ncn(n1)-c1ccccc1)c1cccs1	InChI=1S/C26H27N5OS/c32-25(24-12-7-19-33-24)31(26-27-20-30(28-26)22-10-5-2-6-11-22)23-14-17-29(18-15-23)16-13-21-8-3-1-4-9-21/h1-12,19-20,23H,13-18H2	TUKCMOXNUHJDFK-UHFFFAOYSA-N	432185	N-(1-phenethylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,4-triazol-3-yl)thiophene-2-::US10577360, Example 49	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432185&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035901	438641125							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876903	O=C(N(C1CCN(CCc2ccccc2)CC1)c1ncn(n1)-c1ccccc1)c1cccs1	InChI=1S/C26H27N5OS/c32-25(24-12-7-19-33-24)31(26-27-20-30(28-26)22-10-5-2-6-11-22)23-14-17-29(18-15-23)16-13-21-8-3-1-4-9-21/h1-12,19-20,23H,13-18H2	TUKCMOXNUHJDFK-UHFFFAOYSA-N	432185	N-(1-phenethylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,4-triazol-3-yl)thiophene-2-::US10577360, Example 49	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432185&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035901	438641125							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876904	CN1CCC(CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H26N6O3/c1-17-26-27-24(34-17)18-5-3-7-21(15-18)30-14-11-23(28-30)31(20-9-12-29(2)13-10-20)25(33)19-6-4-8-22(32)16-19/h3-8,11,14-16,20,32H,9-10,12-13H2,1-2H3	SSKFRGYRWADIDS-UHFFFAOYSA-N	432186	3-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-(1-::US10577360, Example 50	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432186&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010325	438641126							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876905	CN1CCC(CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H26N6O3/c1-17-26-27-24(34-17)18-5-3-7-21(15-18)30-14-11-23(28-30)31(20-9-12-29(2)13-10-20)25(33)19-6-4-8-22(32)16-19/h3-8,11,14-16,20,32H,9-10,12-13H2,1-2H3	SSKFRGYRWADIDS-UHFFFAOYSA-N	432186	3-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-(1-::US10577360, Example 50	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432186	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432186&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010325	438641126							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876906	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccc(O)c1	InChI=1S/C31H30N6O3/c1-22-32-33-30(40-22)24-9-5-11-27(19-24)36-18-15-29(34-36)37(31(39)25-10-6-12-28(38)20-25)26-13-16-35(17-14-26)21-23-7-3-2-4-8-23/h2-12,15,18-20,26,38H,13-14,16-17,21H2,1H3	DFNMBZOGVFNMTD-UHFFFAOYSA-N	432187	N-(1-Benzylpiperidin-4-yl)-3-hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-::US10577360, Example 51	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432187&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010003	438641127							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876907	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccc(O)c1	InChI=1S/C31H30N6O3/c1-22-32-33-30(40-22)24-9-5-11-27(19-24)36-18-15-29(34-36)37(31(39)25-10-6-12-28(38)20-25)26-13-16-35(17-14-26)21-23-7-3-2-4-8-23/h2-12,15,18-20,26,38H,13-14,16-17,21H2,1H3	DFNMBZOGVFNMTD-UHFFFAOYSA-N	432187	N-(1-Benzylpiperidin-4-yl)-3-hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-::US10577360, Example 51	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432187&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010003	438641127							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876908	O=C(N(C1CCNCC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C19H20N4OS/c24-19(17-7-4-14-25-17)23(16-8-11-20-12-9-16)18-10-13-22(21-18)15-5-2-1-3-6-15/h1-7,10,13-14,16,20H,8-9,11-12H2	CPYRFWUHMZDSPN-UHFFFAOYSA-N	432188	N-(1-Phenyl-1H-pyrazol-3-yl)-N-piperidin-4-ylthiophene-2-carboxamide::US10577360, Example 52	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432188&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010927	438641128							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876909	O=C(N(C1CCNCC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C19H20N4OS/c24-19(17-7-4-14-25-17)23(16-8-11-20-12-9-16)18-10-13-22(21-18)15-5-2-1-3-6-15/h1-7,10,13-14,16,20H,8-9,11-12H2	CPYRFWUHMZDSPN-UHFFFAOYSA-N	432188	N-(1-Phenyl-1H-pyrazol-3-yl)-N-piperidin-4-ylthiophene-2-carboxamide::US10577360, Example 52	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432188&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010927	438641128							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876910	O=C(N(C1CCCNC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C19H20N4OS/c24-19(17-9-5-13-25-17)23(16-8-4-11-20-14-16)18-10-12-22(21-18)15-6-2-1-3-7-15/h1-3,5-7,9-10,12-13,16,20H,4,8,11,14H2	UQIUSTMFETUXJJ-UHFFFAOYSA-N	432189	N-(1-Phenyl-1H-pyrazol-3-yl)-N-(piperidin-3-yl)thiophene-2-carboxamide::US10577360, Example 53	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432189&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035891	438641129							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876911	O=C(N(C1CCCNC1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C19H20N4OS/c24-19(17-9-5-13-25-17)23(16-8-4-11-20-14-16)18-10-12-22(21-18)15-6-2-1-3-7-15/h1-3,5-7,9-10,12-13,16,20H,4,8,11,14H2	UQIUSTMFETUXJJ-UHFFFAOYSA-N	432189	N-(1-Phenyl-1H-pyrazol-3-yl)-N-(piperidin-3-yl)thiophene-2-carboxamide::US10577360, Example 53	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432189&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035891	438641129							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876912	O=C(N(C1CCNC(Cc2ccccc2)C1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C26H26N4OS/c31-26(24-12-7-17-32-24)30(25-14-16-29(28-25)22-10-5-2-6-11-22)23-13-15-27-21(19-23)18-20-8-3-1-4-9-20/h1-12,14,16-17,21,23,27H,13,15,18-19H2	CLCUSZFETCBYAQ-UHFFFAOYSA-N	432190	N-(2-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 54	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432190&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585163	438641130							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876913	O=C(N(C1CCNC(Cc2ccccc2)C1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C26H26N4OS/c31-26(24-12-7-17-32-24)30(25-14-16-29(28-25)22-10-5-2-6-11-22)23-13-15-27-21(19-23)18-20-8-3-1-4-9-20/h1-12,14,16-17,21,23,27H,13,15,18-19H2	CLCUSZFETCBYAQ-UHFFFAOYSA-N	432190	N-(2-Benzylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 54	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432190&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585163	438641130							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876914	O=C(N(CCNCc1ccccc1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C23H22N4OS/c28-23(21-12-7-17-29-21)26(16-14-24-18-19-8-3-1-4-9-19)22-13-15-27(25-22)20-10-5-2-6-11-20/h1-13,15,17,24H,14,16,18H2	BUAJLHJMWUSDAS-UHFFFAOYSA-N	432191	N-[2-(Benzylamino)ethyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 55	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432191&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010865	438641131							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876915	O=C(N(CCNCc1ccccc1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C23H22N4OS/c28-23(21-12-7-17-29-21)26(16-14-24-18-19-8-3-1-4-9-19)22-13-15-27(25-22)20-10-5-2-6-11-20/h1-13,15,17,24H,14,16,18H2	BUAJLHJMWUSDAS-UHFFFAOYSA-N	432191	N-[2-(Benzylamino)ethyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 55	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432191&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010865	438641131							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876916	O=C(N(CCCNCc1ccccc1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C24H24N4OS/c29-24(22-13-7-18-30-22)27(16-8-15-25-19-20-9-3-1-4-10-20)23-14-17-28(26-23)21-11-5-2-6-12-21/h1-7,9-14,17-18,25H,8,15-16,19H2	FSJINOYIOUTSLT-UHFFFAOYSA-N	432192	N-[3-(Benzylamino)propyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 56	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432192&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036334	438641132							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876917	O=C(N(CCCNCc1ccccc1)c1ccn(n1)-c1ccccc1)c1cccs1	InChI=1S/C24H24N4OS/c29-24(22-13-7-18-30-22)27(16-8-15-25-19-20-9-3-1-4-10-20)23-14-17-28(26-23)21-11-5-2-6-12-21/h1-7,9-14,17-18,25H,8,15-16,19H2	FSJINOYIOUTSLT-UHFFFAOYSA-N	432192	N-[3-(Benzylamino)propyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 56	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432192&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036334	438641132							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876918	CNCCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C17H18N4OS/c1-18-10-12-20(17(22)15-8-5-13-23-15)16-9-11-21(19-16)14-6-3-2-4-7-14/h2-9,11,13,18H,10,12H2,1H3	PZUNNKOFXUVJNV-UHFFFAOYSA-N	432193	N-[2-(Methylamino)ethyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 57	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432193&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010901	438641133							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876919	CNCCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C17H18N4OS/c1-18-10-12-20(17(22)15-8-5-13-23-15)16-9-11-21(19-16)14-6-3-2-4-7-14/h2-9,11,13,18H,10,12H2,1H3	PZUNNKOFXUVJNV-UHFFFAOYSA-N	432193	N-[2-(Methylamino)ethyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 57	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432193&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010901	438641133							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876920	CC(C)CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C23H28N4OS/c1-18(2)17-25-13-10-20(11-14-25)27(23(28)21-9-6-16-29-21)22-12-15-26(24-22)19-7-4-3-5-8-19/h3-9,12,15-16,18,20H,10-11,13-14,17H2,1-2H3	OCVBIAQTAUMZKZ-UHFFFAOYSA-N	432194	N-(1-Isobutylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 58	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432194&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010542	438641134							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876921	CC(C)CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C23H28N4OS/c1-18(2)17-25-13-10-20(11-14-25)27(23(28)21-9-6-16-29-21)22-12-15-26(24-22)19-7-4-3-5-8-19/h3-9,12,15-16,18,20H,10-11,13-14,17H2,1-2H3	OCVBIAQTAUMZKZ-UHFFFAOYSA-N	432194	N-(1-Isobutylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 58	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432194&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010542	438641134							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876922	CCN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C21H24N4OS/c1-2-23-13-10-18(11-14-23)25(21(26)19-9-6-16-27-19)20-12-15-24(22-20)17-7-4-3-5-8-17/h3-9,12,15-16,18H,2,10-11,13-14H2,1H3	YGMBKWSJJBTLCG-UHFFFAOYSA-N	432195	N-(1-Ethylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 59	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432195&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036336	438641135							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876923	CCN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C21H24N4OS/c1-2-23-13-10-18(11-14-23)25(21(26)19-9-6-16-27-19)20-12-15-24(22-20)17-7-4-3-5-8-17/h3-9,12,15-16,18H,2,10-11,13-14H2,1H3	YGMBKWSJJBTLCG-UHFFFAOYSA-N	432195	N-(1-Ethylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 59	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432195&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036336	438641135							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876924	CC(C)N1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H26N4OS/c1-17(2)24-13-10-19(11-14-24)26(22(27)20-9-6-16-28-20)21-12-15-25(23-21)18-7-4-3-5-8-18/h3-9,12,15-17,19H,10-11,13-14H2,1-2H3	FPTFBPOBPFEJJM-UHFFFAOYSA-N	432196	N-(1-Isopropylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 60	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432196&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036337	438641136							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876925	CC(C)N1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H26N4OS/c1-17(2)24-13-10-19(11-14-24)26(22(27)20-9-6-16-28-20)21-12-15-25(23-21)18-7-4-3-5-8-18/h3-9,12,15-17,19H,10-11,13-14H2,1-2H3	FPTFBPOBPFEJJM-UHFFFAOYSA-N	432196	N-(1-Isopropylpiperidin-4-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 60	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432196&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036337	438641136							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876926	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccccc1	InChI=1S/C24H24N4OS/c1-26(19-20-9-4-2-5-10-20)16-17-27(24(29)22-13-8-18-30-22)23-14-15-28(25-23)21-11-6-3-7-12-21/h2-15,18H,16-17,19H2,1H3	WFOYGCRDQVKWBZ-UHFFFAOYSA-N	432197	N-{2-[Benzyl(methyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 61	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432197&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036340	438641137							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876927	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccccc1	InChI=1S/C24H24N4OS/c1-26(19-20-9-4-2-5-10-20)16-17-27(24(29)22-13-8-18-30-22)23-14-15-28(25-23)21-11-6-3-7-12-21/h2-15,18H,16-17,19H2,1H3	WFOYGCRDQVKWBZ-UHFFFAOYSA-N	432197	N-{2-[Benzyl(methyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 61	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432197&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036340	438641137							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876928	CN(CCCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccccc1	InChI=1S/C25H26N4OS/c1-27(20-21-10-4-2-5-11-21)16-9-17-28(25(30)23-14-8-19-31-23)24-15-18-29(26-24)22-12-6-3-7-13-22/h2-8,10-15,18-19H,9,16-17,20H2,1H3	BZGAOGDLJCLITM-UHFFFAOYSA-N	432198	N-{3-[Benzyl(methyl)amino]propyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 62	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432198&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036072	438641138							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876929	CN(CCCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccccc1	InChI=1S/C25H26N4OS/c1-27(20-21-10-4-2-5-11-21)16-9-17-28(25(30)23-14-8-19-31-23)24-15-18-29(26-24)22-12-6-3-7-13-22/h2-8,10-15,18-19H,9,16-17,20H2,1H3	BZGAOGDLJCLITM-UHFFFAOYSA-N	432198	N-{3-[Benzyl(methyl)amino]propyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 62	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432198&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036072	438641138							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876930	CCN(C)CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C19H22N4OS/c1-3-21(2)13-14-22(19(24)17-10-7-15-25-17)18-11-12-23(20-18)16-8-5-4-6-9-16/h4-12,15H,3,13-14H2,1-2H3	BMFKLWHNGBQTAQ-UHFFFAOYSA-N	432199	N-{2-[Benzyl(methyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 63	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432199&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138605732	438641139							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876931	CCN(C)CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C19H22N4OS/c1-3-21(2)13-14-22(19(24)17-10-7-15-25-17)18-11-12-23(20-18)16-8-5-4-6-9-16/h4-12,15H,3,13-14H2,1-2H3	BMFKLWHNGBQTAQ-UHFFFAOYSA-N	432199	N-{2-[Benzyl(methyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 63	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432199&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138605732	438641139							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876932	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccncc1	InChI=1S/C23H23N5OS/c1-26(18-19-9-12-24-13-10-19)15-16-27(23(29)21-8-5-17-30-21)22-11-14-28(25-22)20-6-3-2-4-7-20/h2-14,17H,15-16,18H2,1H3	MCLFAHDEPFIJGD-UHFFFAOYSA-N	432201	N-{2-[Methyl(pyridin-4-ylmethyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-::US10577360, Example 64	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432201&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036070	438641141							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876933	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccncc1	InChI=1S/C23H23N5OS/c1-26(18-19-9-12-24-13-10-19)15-16-27(23(29)21-8-5-17-30-21)22-11-14-28(25-22)20-6-3-2-4-7-20/h2-14,17H,15-16,18H2,1H3	MCLFAHDEPFIJGD-UHFFFAOYSA-N	432201	N-{2-[Methyl(pyridin-4-ylmethyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-::US10577360, Example 64	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432201&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036070	438641141							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876934	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1cccnc1	InChI=1S/C23H23N5OS/c1-26(18-19-7-5-12-24-17-19)14-15-27(23(29)21-10-6-16-30-21)22-11-13-28(25-22)20-8-3-2-4-9-20/h2-13,16-17H,14-15,18H2,1H3	QHXOJMNQKHSXGS-UHFFFAOYSA-N	432202	N-{2-[Methyl(pyridin-4-ylmethyl)amino]ethyl}-N-(1-phenyl-1H-py-razol-3-::US10577360, Example 65	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432202&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036078	438641142							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876935	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1cccnc1	InChI=1S/C23H23N5OS/c1-26(18-19-7-5-12-24-17-19)14-15-27(23(29)21-10-6-16-30-21)22-11-13-28(25-22)20-8-3-2-4-9-20/h2-13,16-17H,14-15,18H2,1H3	QHXOJMNQKHSXGS-UHFFFAOYSA-N	432202	N-{2-[Methyl(pyridin-4-ylmethyl)amino]ethyl}-N-(1-phenyl-1H-py-razol-3-::US10577360, Example 65	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432202&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036078	438641142							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876936	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccccn1	InChI=1S/C23H23N5OS/c1-26(18-19-8-5-6-13-24-19)15-16-27(23(29)21-11-7-17-30-21)22-12-14-28(25-22)20-9-3-2-4-10-20/h2-14,17H,15-16,18H2,1H3	NSGWLLWGACLGPV-UHFFFAOYSA-N	432203	N-{2-[Methyl(pyridin-4-ylmethyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-::US10577360, Example 66	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432203&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036074	438641143							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876937	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1)Cc1ccccn1	InChI=1S/C23H23N5OS/c1-26(18-19-8-5-6-13-24-19)15-16-27(23(29)21-11-7-17-30-21)22-12-14-28(25-22)20-9-3-2-4-10-20/h2-14,17H,15-16,18H2,1H3	NSGWLLWGACLGPV-UHFFFAOYSA-N	432203	N-{2-[Methyl(pyridin-4-ylmethyl)amino]ethyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-::US10577360, Example 66	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432203&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036074	438641143							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876938	CN1CCCC(C1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H22N4OS/c1-22-12-5-9-17(15-22)24(20(25)18-10-6-14-26-18)19-11-13-23(21-19)16-7-3-2-4-8-16/h2-4,6-8,10-11,13-14,17H,5,9,12,15H2,1H3	VEHFVKPBERUKPI-UHFFFAOYSA-N	432204	N-(1-Methylpiperidin-3-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 67	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432204&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585141	438641144							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876939	CN1CCCC(C1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C20H22N4OS/c1-22-12-5-9-17(15-22)24(20(25)18-10-6-14-26-18)19-11-13-23(21-19)16-7-3-2-4-8-16/h2-4,6-8,10-11,13-14,17H,5,9,12,15H2,1H3	VEHFVKPBERUKPI-UHFFFAOYSA-N	432204	N-(1-Methylpiperidin-3-yl)-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 67	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432204&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585141	438641144							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876940	CCNCCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C18H20N4OS/c1-2-19-11-13-21(18(23)16-9-6-14-24-16)17-10-12-22(20-17)15-7-4-3-5-8-15/h3-10,12,14,19H,2,11,13H2,1H3	ZYJDVHQHABTCFB-UHFFFAOYSA-N	432205	N-[2-(Ethylamino)ethyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 68	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432205&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036071	438641145							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876941	CCNCCN(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C18H20N4OS/c1-2-19-11-13-21(18(23)16-9-6-14-24-16)17-10-12-22(20-17)15-7-4-3-5-8-15/h3-10,12,14,19H,2,11,13H2,1H3	ZYJDVHQHABTCFB-UHFFFAOYSA-N	432205	N-[2-(Ethylamino)ethyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-carboxamide::US10577360, Example 68	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432205&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036071	438641145							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876942	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1)Cc1ccccc1	InChI=1S/C27H26N6O2S/c1-20-28-29-26(35-20)22-10-6-11-23(18-22)33-14-13-25(30-33)32(27(34)24-12-7-17-36-24)16-15-31(2)19-21-8-4-3-5-9-21/h3-14,17-18H,15-16,19H2,1-2H3	RPXPWMCLPCDNRN-UHFFFAOYSA-N	432206	N-{2-[Benzyl(methyl)amino]ethyl}-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 69	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432206&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132011038	438641146							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876943	CN(CCN(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1)Cc1ccccc1	InChI=1S/C27H26N6O2S/c1-20-28-29-26(35-20)22-10-6-11-23(18-22)33-14-13-25(30-33)32(27(34)24-12-7-17-36-24)16-15-31(2)19-21-8-4-3-5-9-21/h3-14,17-18H,15-16,19H2,1-2H3	RPXPWMCLPCDNRN-UHFFFAOYSA-N	432206	N-{2-[Benzyl(methyl)amino]ethyl}-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 69	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432206&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132011038	438641146							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876944	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccn1	InChI=1S/C19H21N5OS/c1-22-11-7-15(8-12-22)24(19(25)16-5-4-14-26-16)18-9-13-23(21-18)17-6-2-3-10-20-17/h2-6,9-10,13-15H,7-8,11-12H2,1H3	PVAZWXZOFZTKOK-UHFFFAOYSA-N	432207	N-(1-Methylpiperidin-4-yl)-N-(1-pyridin-2-yl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 70	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432207&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138605729	438641147							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876945	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccn1	InChI=1S/C19H21N5OS/c1-22-11-7-15(8-12-22)24(19(25)16-5-4-14-26-16)18-9-13-23(21-18)17-6-2-3-10-20-17/h2-6,9-10,13-15H,7-8,11-12H2,1H3	PVAZWXZOFZTKOK-UHFFFAOYSA-N	432207	N-(1-Methylpiperidin-4-yl)-N-(1-pyridin-2-yl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 70	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432207&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138605729	438641147							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876946	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccnc1	InChI=1S/C19H21N5OS/c1-22-10-6-15(7-11-22)24(19(25)17-5-3-13-26-17)18-8-12-23(21-18)16-4-2-9-20-14-16/h2-5,8-9,12-15H,6-7,10-11H2,1H3	QDYDLZNPLZJWOY-UHFFFAOYSA-N	432208	N-(1-Methylpiperidin-4-yl)-N-[1-(pyridin-3-yl)-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 71	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432208&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585188	438641148							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876947	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccnc1	InChI=1S/C19H21N5OS/c1-22-10-6-15(7-11-22)24(19(25)17-5-3-13-26-17)18-8-12-23(21-18)16-4-2-9-20-14-16/h2-5,8-9,12-15H,6-7,10-11H2,1H3	QDYDLZNPLZJWOY-UHFFFAOYSA-N	432208	N-(1-Methylpiperidin-4-yl)-N-[1-(pyridin-3-yl)-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 71	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432208&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585188	438641148							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876948	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccncc1F	InChI=1S/C19H20FN5OS/c1-23-9-5-14(6-10-23)25(19(26)17-3-2-12-27-17)18-7-11-24(22-18)16-4-8-21-13-15(16)20/h2-4,7-8,11-14H,5-6,9-10H2,1H3	XZVPVNUTGUDIDJ-UHFFFAOYSA-N	432209	N-[1-(3-Fluoropyridin-4-yl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 72	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432209&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584987	438641149							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876949	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccncc1F	InChI=1S/C19H20FN5OS/c1-23-9-5-14(6-10-23)25(19(26)17-3-2-12-27-17)18-7-11-24(22-18)16-4-8-21-13-15(16)20/h2-4,7-8,11-14H,5-6,9-10H2,1H3	XZVPVNUTGUDIDJ-UHFFFAOYSA-N	432209	N-[1-(3-Fluoropyridin-4-yl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 72	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432209&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584987	438641149							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876950	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccncc1C	InChI=1S/C20H23N5OS/c1-15-14-21-9-5-17(15)24-12-8-19(22-24)25(16-6-10-23(2)11-7-16)20(26)18-4-3-13-27-18/h3-5,8-9,12-14,16H,6-7,10-11H2,1-2H3	OCDBQLHTDKSPPU-UHFFFAOYSA-N	432210	N-(1-Methylpiperidin-4-yl)-N-[1-(3-methylpyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 73	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432210&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584933	438641150							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876951	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccncc1C	InChI=1S/C20H23N5OS/c1-15-14-21-9-5-17(15)24-12-8-19(22-24)25(16-6-10-23(2)11-7-16)20(26)18-4-3-13-27-18/h3-5,8-9,12-14,16H,6-7,10-11H2,1-2H3	OCDBQLHTDKSPPU-UHFFFAOYSA-N	432210	N-(1-Methylpiperidin-4-yl)-N-[1-(3-methylpyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 73	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432210&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584933	438641150							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876952	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1C	InChI=1S/C21H24N4OS/c1-16-6-3-4-7-18(16)24-14-11-20(22-24)25(17-9-12-23(2)13-10-17)21(26)19-8-5-15-27-19/h3-8,11,14-15,17H,9-10,12-13H2,1-2H3	YFAHFKPROXTDKZ-UHFFFAOYSA-N	432211	N-(1-Methylpiperidin-4-yl)-N-[1-(o-tolyl)-1H-pyrazol-3-yl]thiophene-2-carboxamide::US10577360, Example 74	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432211&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584841	438641151							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876953	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1C	InChI=1S/C21H24N4OS/c1-16-6-3-4-7-18(16)24-14-11-20(22-24)25(17-9-12-23(2)13-10-17)21(26)19-8-5-15-27-19/h3-8,11,14-15,17H,9-10,12-13H2,1-2H3	YFAHFKPROXTDKZ-UHFFFAOYSA-N	432211	N-(1-Methylpiperidin-4-yl)-N-[1-(o-tolyl)-1H-pyrazol-3-yl]thiophene-2-carboxamide::US10577360, Example 74	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432211&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584841	438641151							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876954	COCCOc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C23H28N4O3S/c1-25-11-8-18(9-12-25)27(23(28)21-7-4-16-31-21)22-10-13-26(24-22)19-5-3-6-20(17-19)30-15-14-29-2/h3-7,10,13,16-18H,8-9,11-12,14-15H2,1-2H3	IBBUCNOIMMVXNM-UHFFFAOYSA-N	432212	N-{1-[3-(2-Methoxyethoxy)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-::US10577360, Example 75	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432212&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584994	438641152							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876955	COCCOc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C23H28N4O3S/c1-25-11-8-18(9-12-25)27(23(28)21-7-4-16-31-21)22-10-13-26(24-22)19-5-3-6-20(17-19)30-15-14-29-2/h3-7,10,13,16-18H,8-9,11-12,14-15H2,1-2H3	IBBUCNOIMMVXNM-UHFFFAOYSA-N	432212	N-{1-[3-(2-Methoxyethoxy)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-::US10577360, Example 75	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432212&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584994	438641152							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876956	COc1cc(C)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O2S/c1-16-13-18(15-19(14-16)28-3)25-11-8-21(23-25)26(17-6-9-24(2)10-7-17)22(27)20-5-4-12-29-20/h4-5,8,11-15,17H,6-7,9-10H2,1-3H3	QPNSVEHAMHUCOU-UHFFFAOYSA-N	432213	N-[1-(3-Methoxy-5-methylphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 76	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432213&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584935	438641153							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876957	COc1cc(C)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O2S/c1-16-13-18(15-19(14-16)28-3)25-11-8-21(23-25)26(17-6-9-24(2)10-7-17)22(27)20-5-4-12-29-20/h4-5,8,11-15,17H,6-7,9-10H2,1-3H3	QPNSVEHAMHUCOU-UHFFFAOYSA-N	432213	N-[1-(3-Methoxy-5-methylphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 76	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432213&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584935	438641153							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876958	Clc1cncc(Cl)c1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H23Cl2N5OS/c26-20-15-28-16-21(27)24(20)31-13-10-23(29-31)32(25(33)22-7-4-14-34-22)19-8-11-30(12-9-19)17-18-5-2-1-3-6-18/h1-7,10,13-16,19H,8-9,11-12,17H2	HQCPGYXRNWTNRE-UHFFFAOYSA-N	432214	N-(1-Benzylpiperidin-4-yl)-N-[1-(3,5-dichloropyridin-4-yl)-1H-pyrazol-3-yl]thiophene-::US10577360, Example 77	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432214&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035753	438641154							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876959	Clc1cncc(Cl)c1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H23Cl2N5OS/c26-20-15-28-16-21(27)24(20)31-13-10-23(29-31)32(25(33)22-7-4-14-34-22)19-8-11-30(12-9-19)17-18-5-2-1-3-6-18/h1-7,10,13-16,19H,8-9,11-12,17H2	HQCPGYXRNWTNRE-UHFFFAOYSA-N	432214	N-(1-Benzylpiperidin-4-yl)-N-[1-(3,5-dichloropyridin-4-yl)-1H-pyrazol-3-yl]thiophene-::US10577360, Example 77	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432214&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035753	438641154							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876960	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccncc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-7-4-18-32-23)30(24-12-17-29(27-24)21-8-13-26-14-9-21)22-10-15-28(16-11-22)19-20-5-2-1-3-6-20/h1-9,12-14,17-18,22H,10-11,15-16,19H2	NBPWXQDCXKUZSF-UHFFFAOYSA-N	432215	N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 78	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432215&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035754	438641155							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876961	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccncc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-7-4-18-32-23)30(24-12-17-29(27-24)21-8-13-26-14-9-21)22-10-15-28(16-11-22)19-20-5-2-1-3-6-20/h1-9,12-14,17-18,22H,10-11,15-16,19H2	NBPWXQDCXKUZSF-UHFFFAOYSA-N	432215	N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 78	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432215&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035754	438641155							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876962	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1cccnc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-9-5-17-32-23)30(24-12-16-29(27-24)22-8-4-13-26-18-22)21-10-14-28(15-11-21)19-20-6-2-1-3-7-20/h1-9,12-13,16-18,21H,10-11,14-15,19H2	LBYJUYNTJFQZEV-UHFFFAOYSA-N	432216	N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-3-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 79	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432216&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035756	438641156							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876963	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1cccnc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-9-5-17-32-23)30(24-12-16-29(27-24)22-8-4-13-26-18-22)21-10-14-28(15-11-21)19-20-6-2-1-3-7-20/h1-9,12-13,16-18,21H,10-11,14-15,19H2	LBYJUYNTJFQZEV-UHFFFAOYSA-N	432216	N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-3-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 79	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432216&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035756	438641156							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876964	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccn1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(22-9-6-18-32-22)30(24-13-17-29(27-24)23-10-4-5-14-26-23)21-11-15-28(16-12-21)19-20-7-2-1-3-8-20/h1-10,13-14,17-18,21H,11-12,15-16,19H2	HFXBOXCRKDTECC-UHFFFAOYSA-N	432217	N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-2-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 80	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432217&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585140	438641157							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876965	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccccn1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(22-9-6-18-32-22)30(24-13-17-29(27-24)23-10-4-5-14-26-23)21-11-15-28(16-12-21)19-20-7-2-1-3-8-20/h1-10,13-14,17-18,21H,11-12,15-16,19H2	HFXBOXCRKDTECC-UHFFFAOYSA-N	432217	N-(1-Benzylpiperidin-4-yl)-N-[1-(pyridin-2-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 80	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432217&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585140	438641157							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876966	Cc1ccccc1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H28N4OS/c1-21-8-5-6-11-24(21)30-18-15-26(28-30)31(27(32)25-12-7-19-33-25)23-13-16-29(17-14-23)20-22-9-3-2-4-10-22/h2-12,15,18-19,23H,13-14,16-17,20H2,1H3	NPGCMVNZNBKUKY-UHFFFAOYSA-N	432218	N-(1-Benzylpiperidin-4-yl)-N-[1-(o-tolyl)-1H-pyrazol-3-yl]thiophene-2-carboxamide::US10577360, Example 81	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432218&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035755	438641158							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876967	Cc1ccccc1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C27H28N4OS/c1-21-8-5-6-11-24(21)30-18-15-26(28-30)31(27(32)25-12-7-19-33-25)23-13-16-29(17-14-23)20-22-9-3-2-4-10-22/h2-12,15,18-19,23H,13-14,16-17,20H2,1H3	NPGCMVNZNBKUKY-UHFFFAOYSA-N	432218	N-(1-Benzylpiperidin-4-yl)-N-[1-(o-tolyl)-1H-pyrazol-3-yl]thiophene-2-carboxamide::US10577360, Example 81	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432218&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035755	438641158							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876968	Fc1cnccc1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H24FN5OS/c26-21-17-27-12-8-22(21)30-15-11-24(28-30)31(25(32)23-7-4-16-33-23)20-9-13-29(14-10-20)18-19-5-2-1-3-6-19/h1-8,11-12,15-17,20H,9-10,13-14,18H2	MBNHVDNVTPULCJ-UHFFFAOYSA-N	432219	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-fluoropyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 82	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432219&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035905	438641159							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876969	Fc1cnccc1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H24FN5OS/c26-21-17-27-12-8-22(21)30-15-11-24(28-30)31(25(32)23-7-4-16-33-23)20-9-13-29(14-10-20)18-19-5-2-1-3-6-19/h1-8,11-12,15-17,20H,9-10,13-14,18H2	MBNHVDNVTPULCJ-UHFFFAOYSA-N	432219	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-fluoropyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 82	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432219&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035905	438641159							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876970	Clc1cnccc1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H24ClN5OS/c26-21-17-27-12-8-22(21)30-15-11-24(28-30)31(25(32)23-7-4-16-33-23)20-9-13-29(14-10-20)18-19-5-2-1-3-6-19/h1-8,11-12,15-17,20H,9-10,13-14,18H2	JDYWLKYFHXFYOB-UHFFFAOYSA-N	432220	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-chloropyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 83	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432220&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585098	438641160							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876971	Clc1cnccc1-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H24ClN5OS/c26-21-17-27-12-8-22(21)30-15-11-24(28-30)31(25(32)23-7-4-16-33-23)20-9-13-29(14-10-20)18-19-5-2-1-3-6-19/h1-8,11-12,15-17,20H,9-10,13-14,18H2	JDYWLKYFHXFYOB-UHFFFAOYSA-N	432220	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-chloropyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 83	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432220&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585098	438641160							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876972	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccc(F)c(F)c2)CC1)C(=O)c1cccs1	InChI=1S/C29H26F2N6O2S/c1-19-32-33-28(39-19)21-4-2-5-23(17-21)36-14-11-27(34-36)37(29(38)26-6-3-15-40-26)22-9-12-35(13-10-22)18-20-7-8-24(30)25(31)16-20/h2-8,11,14-17,22H,9-10,12-13,18H2,1H3	JDNCTXIGEUBHDF-UHFFFAOYSA-N	432221	N-[1-(3,4-Difluorobenzyl)piperidin-4-yl]-N-(1-[3-(5-methyl-1,3,4-oxadiazol-2-::US10577360, Example 84	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432221&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585076	438641161							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876973	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccc(F)c(F)c2)CC1)C(=O)c1cccs1	InChI=1S/C29H26F2N6O2S/c1-19-32-33-28(39-19)21-4-2-5-23(17-21)36-14-11-27(34-36)37(29(38)26-6-3-15-40-26)22-9-12-35(13-10-22)18-20-7-8-24(30)25(31)16-20/h2-8,11,14-17,22H,9-10,12-13,18H2,1H3	JDNCTXIGEUBHDF-UHFFFAOYSA-N	432221	N-[1-(3,4-Difluorobenzyl)piperidin-4-yl]-N-(1-[3-(5-methyl-1,3,4-oxadiazol-2-::US10577360, Example 84	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432221&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585076	438641161							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876974	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccn2)CC1)C(=O)c1cccs1	InChI=1S/C28H27N7O2S/c1-20-30-31-27(37-20)21-6-4-8-24(18-21)34-16-12-26(32-34)35(28(36)25-9-5-17-38-25)23-10-14-33(15-11-23)19-22-7-2-3-13-29-22/h2-9,12-13,16-18,23H,10-11,14-15,19H2,1H3	DMGZJIZQYPBJRJ-UHFFFAOYSA-N	432222	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-(1-pyridin-2-::US10577360, Example 86	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432222&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585195	438641162							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876975	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccn2)CC1)C(=O)c1cccs1	InChI=1S/C28H27N7O2S/c1-20-30-31-27(37-20)21-6-4-8-24(18-21)34-16-12-26(32-34)35(28(36)25-9-5-17-38-25)23-10-14-33(15-11-23)19-22-7-2-3-13-29-22/h2-9,12-13,16-18,23H,10-11,14-15,19H2,1H3	DMGZJIZQYPBJRJ-UHFFFAOYSA-N	432222	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-(1-pyridin-2-::US10577360, Example 86	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432222&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585195	438641162							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876976	CCOc1ccc(cc1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O2S/c1-3-28-19-8-6-17(7-9-19)25-15-12-21(23-25)26(18-10-13-24(2)14-11-18)22(27)20-5-4-16-29-20/h4-9,12,15-16,18H,3,10-11,13-14H2,1-2H3	GALKUYMRVMPPQZ-UHFFFAOYSA-N	432223	N-[1-(4-Ethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 87	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432223&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010669	438641163							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876977	CCOc1ccc(cc1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O2S/c1-3-28-19-8-6-17(7-9-19)25-15-12-21(23-25)26(18-10-13-24(2)14-11-18)22(27)20-5-4-16-29-20/h4-9,12,15-16,18H,3,10-11,13-14H2,1-2H3	GALKUYMRVMPPQZ-UHFFFAOYSA-N	432223	N-[1-(4-Ethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 87	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432223&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010669	438641163							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876978	CCOc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O2S/c1-3-28-19-7-4-6-18(16-19)25-14-11-21(23-25)26(17-9-12-24(2)13-10-17)22(27)20-8-5-15-29-20/h4-8,11,14-17H,3,9-10,12-13H2,1-2H3	IICRKUSBTTWNSH-UHFFFAOYSA-N	432224	N-[1-(3-Ethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 88	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432224&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585145	438641164							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876979	CCOc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O2S/c1-3-28-19-7-4-6-18(16-19)25-14-11-21(23-25)26(17-9-12-24(2)13-10-17)22(27)20-8-5-15-29-20/h4-8,11,14-17H,3,9-10,12-13H2,1-2H3	IICRKUSBTTWNSH-UHFFFAOYSA-N	432224	N-[1-(3-Ethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 88	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432224&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585145	438641164							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876980	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(cc1)C#N	InChI=1S/C21H21N5OS/c1-24-11-8-18(9-12-24)26(21(27)19-3-2-14-28-19)20-10-13-25(23-20)17-6-4-16(15-22)5-7-17/h2-7,10,13-14,18H,8-9,11-12H2,1H3	HORLRCMRIBAKMX-UHFFFAOYSA-N	432225	N-[1-(4-Cyanophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 89	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432225&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036155	438641165							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876981	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(cc1)C#N	InChI=1S/C21H21N5OS/c1-24-11-8-18(9-12-24)26(21(27)19-3-2-14-28-19)20-10-13-25(23-20)17-6-4-16(15-22)5-7-17/h2-7,10,13-14,18H,8-9,11-12H2,1H3	HORLRCMRIBAKMX-UHFFFAOYSA-N	432225	N-[1-(4-Cyanophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 89	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432225&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036155	438641165							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876982	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)C#N	InChI=1S/C21H21N5OS/c1-24-10-7-17(8-11-24)26(21(27)19-6-3-13-28-19)20-9-12-25(23-20)18-5-2-4-16(14-18)15-22/h2-6,9,12-14,17H,7-8,10-11H2,1H3	CPFPFOXWLSNAHH-UHFFFAOYSA-N	432226	N-[1-(3-Cyanophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 90	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432226&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036150	438641166							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876983	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)C#N	InChI=1S/C21H21N5OS/c1-24-10-7-17(8-11-24)26(21(27)19-6-3-13-28-19)20-9-12-25(23-20)18-5-2-4-16(14-18)15-22/h2-6,9,12-14,17H,7-8,10-11H2,1H3	CPFPFOXWLSNAHH-UHFFFAOYSA-N	432226	N-[1-(3-Cyanophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 90	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432226&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036150	438641166							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876984	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(F)cc1	InChI=1S/C20H21FN4OS/c1-23-11-8-17(9-12-23)25(20(26)18-3-2-14-27-18)19-10-13-24(22-19)16-6-4-15(21)5-7-16/h2-7,10,13-14,17H,8-9,11-12H2,1H3	PCWCDWUAQRGSOG-UHFFFAOYSA-N	432227	N-[1-(4-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 91	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432227&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584940	438641167							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876985	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(F)cc1	InChI=1S/C20H21FN4OS/c1-23-11-8-17(9-12-23)25(20(26)18-3-2-14-27-18)19-10-13-24(22-19)16-6-4-15(21)5-7-16/h2-7,10,13-14,17H,8-9,11-12H2,1H3	PCWCDWUAQRGSOG-UHFFFAOYSA-N	432227	N-[1-(4-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 91	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432227&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584940	438641167							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876986	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(F)c1	InChI=1S/C20H21FN4OS/c1-23-10-7-16(8-11-23)25(20(26)18-6-3-13-27-18)19-9-12-24(22-19)17-5-2-4-15(21)14-17/h2-6,9,12-14,16H,7-8,10-11H2,1H3	XGDQZEUQFRBIRK-UHFFFAOYSA-N	432228	N-[1-(3-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 92	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432228&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036348	438641168							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876987	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(F)c1	InChI=1S/C20H21FN4OS/c1-23-10-7-16(8-11-23)25(20(26)18-6-3-13-27-18)19-9-12-24(22-19)17-5-2-4-15(21)14-17/h2-6,9,12-14,16H,7-8,10-11H2,1H3	XGDQZEUQFRBIRK-UHFFFAOYSA-N	432228	N-[1-(3-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 92	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432228&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036348	438641168							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876988	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1F	InChI=1S/C20H21FN4OS/c1-23-11-8-15(9-12-23)25(20(26)18-7-4-14-27-18)19-10-13-24(22-19)17-6-3-2-5-16(17)21/h2-7,10,13-15H,8-9,11-12H2,1H3	RSCUFYISAOQXFH-UHFFFAOYSA-N	432229	N-[1-(2-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 93	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432229&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036346	438641169							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876989	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1F	InChI=1S/C20H21FN4OS/c1-23-11-8-15(9-12-23)25(20(26)18-7-4-14-27-18)19-10-13-24(22-19)17-6-3-2-5-16(17)21/h2-7,10,13-15H,8-9,11-12H2,1H3	RSCUFYISAOQXFH-UHFFFAOYSA-N	432229	N-[1-(2-Fluorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 93	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432229&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036346	438641169							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876990	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccncc1	InChI=1S/C19H21N5OS/c1-22-11-6-16(7-12-22)24(19(25)17-3-2-14-26-17)18-8-13-23(21-18)15-4-9-20-10-5-15/h2-5,8-10,13-14,16H,6-7,11-12H2,1H3	WJGCUZBJVKHCCH-UHFFFAOYSA-N	432230	N-(1-Methylpiperidin-4-yl)-N-[1-(pyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 94	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432230&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584919	438641170							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876991	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccncc1	InChI=1S/C19H21N5OS/c1-22-11-6-16(7-12-22)24(19(25)17-3-2-14-26-17)18-8-13-23(21-18)15-4-9-20-10-5-15/h2-5,8-10,13-14,16H,6-7,11-12H2,1H3	WJGCUZBJVKHCCH-UHFFFAOYSA-N	432230	N-(1-Methylpiperidin-4-yl)-N-[1-(pyridin-4-yl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 94	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432230&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584919	438641170							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876992	COc1ccc(cc1OC)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O3S/c1-24-11-8-16(9-12-24)26(22(27)20-5-4-14-30-20)21-10-13-25(23-21)17-6-7-18(28-2)19(15-17)29-3/h4-7,10,13-16H,8-9,11-12H2,1-3H3	NTYNLAUIRHQIBF-UHFFFAOYSA-N	432231	N-[1-(3,4-Dimethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 95	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432231&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036354	438641171							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876993	COc1ccc(cc1OC)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O3S/c1-24-11-8-16(9-12-24)26(22(27)20-5-4-14-30-20)21-10-13-25(23-21)17-6-7-18(28-2)19(15-17)29-3/h4-7,10,13-16H,8-9,11-12H2,1-3H3	NTYNLAUIRHQIBF-UHFFFAOYSA-N	432231	N-[1-(3,4-Dimethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 95	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432231&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036354	438641171							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876994	COc1ccc(c(Cl)c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23ClN4O2S/c1-24-10-7-15(8-11-24)26(21(27)19-4-3-13-29-19)20-9-12-25(23-20)18-6-5-16(28-2)14-17(18)22/h3-6,9,12-15H,7-8,10-11H2,1-2H3	SHSISJATEIPPDR-UHFFFAOYSA-N	432232	N-[1-(2-Chloro-4-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 96	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432232&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036345	438641172							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876995	COc1ccc(c(Cl)c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23ClN4O2S/c1-24-10-7-15(8-11-24)26(21(27)19-4-3-13-29-19)20-9-12-25(23-20)18-6-5-16(28-2)14-17(18)22/h3-6,9,12-15H,7-8,10-11H2,1-2H3	SHSISJATEIPPDR-UHFFFAOYSA-N	432232	N-[1-(2-Chloro-4-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 96	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432232&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036345	438641172							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876996	COc1ccc(cn1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C20H23N5O2S/c1-23-10-7-15(8-11-23)25(20(26)17-4-3-13-28-17)18-9-12-24(22-18)16-5-6-19(27-2)21-14-16/h3-6,9,12-15H,7-8,10-11H2,1-2H3	VOQUSOZGCHDTFQ-UHFFFAOYSA-N	432233	N-[1-(6-Methoxypyridin-3-yl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 97	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432233&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036162	438641173							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876997	COc1ccc(cn1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C20H23N5O2S/c1-23-10-7-15(8-11-23)25(20(26)17-4-3-13-28-17)18-9-12-24(22-18)16-5-6-19(27-2)21-14-16/h3-6,9,12-15H,7-8,10-11H2,1-2H3	VOQUSOZGCHDTFQ-UHFFFAOYSA-N	432233	N-[1-(6-Methoxypyridin-3-yl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 97	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432233&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036162	438641173							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876998	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(Cl)cc1Cl	InChI=1S/C20H20Cl2N4OS/c1-24-9-6-15(7-10-24)26(20(27)18-3-2-12-28-18)19-8-11-25(23-19)17-5-4-14(21)13-16(17)22/h2-5,8,11-13,15H,6-7,9-10H2,1H3	MSZOXRFLSUIPSC-UHFFFAOYSA-N	432234	N-[1-(2,4-Dichlorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 98	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432234&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036151	438641174							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
876999	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(Cl)cc1Cl	InChI=1S/C20H20Cl2N4OS/c1-24-9-6-15(7-10-24)26(20(27)18-3-2-12-28-18)19-8-11-25(23-19)17-5-4-14(21)13-16(17)22/h2-5,8,11-13,15H,6-7,9-10H2,1H3	MSZOXRFLSUIPSC-UHFFFAOYSA-N	432234	N-[1-(2,4-Dichlorophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 98	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432234&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036151	438641174							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877000	COc1cc(ccc1F)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23FN4O2S/c1-24-10-7-15(8-11-24)26(21(27)19-4-3-13-29-19)20-9-12-25(23-20)16-5-6-17(22)18(14-16)28-2/h3-6,9,12-15H,7-8,10-11H2,1-2H3	DLNVOANKZNHZOR-UHFFFAOYSA-N	432235	N-[1-(4-Fluoro-3-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 99	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432235&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585078	438641175							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877001	COc1cc(ccc1F)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23FN4O2S/c1-24-10-7-15(8-11-24)26(21(27)19-4-3-13-29-19)20-9-12-25(23-20)16-5-6-17(22)18(14-16)28-2/h3-6,9,12-15H,7-8,10-11H2,1-2H3	DLNVOANKZNHZOR-UHFFFAOYSA-N	432235	N-[1-(4-Fluoro-3-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 99	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432235&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585078	438641175							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877002	COc1ccc(Cl)c(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23ClN4O2S/c1-24-10-7-15(8-11-24)26(21(27)19-4-3-13-29-19)20-9-12-25(23-20)18-14-16(28-2)5-6-17(18)22/h3-6,9,12-15H,7-8,10-11H2,1-2H3	FYCSYYLVDQGLPS-UHFFFAOYSA-N	432236	N-[1-(2-Chloro-5-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 100	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432236&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585056	438641176							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877003	COc1ccc(Cl)c(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23ClN4O2S/c1-24-10-7-15(8-11-24)26(21(27)19-4-3-13-29-19)20-9-12-25(23-20)18-14-16(28-2)5-6-17(18)22/h3-6,9,12-15H,7-8,10-11H2,1-2H3	FYCSYYLVDQGLPS-UHFFFAOYSA-N	432236	N-[1-(2-Chloro-5-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 100	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432236&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585056	438641176							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877004	COc1cc(OC)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O3S/c1-24-9-6-16(7-10-24)26(22(27)20-5-4-12-30-20)21-8-11-25(23-21)17-13-18(28-2)15-19(14-17)29-3/h4-5,8,11-16H,6-7,9-10H2,1-3H3	GMHLPBJUUVLHIF-UHFFFAOYSA-N	432237	N-[1-(3,5-Dimethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 101	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432237&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036167	438641177							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877005	COc1cc(OC)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H26N4O3S/c1-24-9-6-16(7-10-24)26(22(27)20-5-4-12-30-20)21-8-11-25(23-21)17-13-18(28-2)15-19(14-17)29-3/h4-5,8,11-16H,6-7,9-10H2,1-3H3	GMHLPBJUUVLHIF-UHFFFAOYSA-N	432237	N-[1-(3,5-Dimethoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 101	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432237&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036167	438641177							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877006	COc1cc(Cl)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23ClN4O2S/c1-24-8-5-16(6-9-24)26(21(27)19-4-3-11-29-19)20-7-10-25(23-20)17-12-15(22)13-18(14-17)28-2/h3-4,7,10-14,16H,5-6,8-9H2,1-2H3	HJSITQBMYZBPIN-UHFFFAOYSA-N	432238	N-[1-(3-Chloro-5-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 102	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432238&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036026	438641178							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877007	COc1cc(Cl)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23ClN4O2S/c1-24-8-5-16(6-9-24)26(21(27)19-4-3-11-29-19)20-7-10-25(23-20)17-12-15(22)13-18(14-17)28-2/h3-4,7,10-14,16H,5-6,8-9H2,1-2H3	HJSITQBMYZBPIN-UHFFFAOYSA-N	432238	N-[1-(3-Chloro-5-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 102	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432238&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036026	438641178							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877008	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(OC(F)(F)F)c1	InChI=1S/C21H21F3N4O2S/c1-26-10-7-15(8-11-26)28(20(29)18-6-3-13-31-18)19-9-12-27(25-19)16-4-2-5-17(14-16)30-21(22,23)24/h2-6,9,12-15H,7-8,10-11H2,1H3	NVSATIAIGKWSAX-UHFFFAOYSA-N	432239	N-(1-Methylpiperidin-4-yl)-N-{1-[3-(trifluoromethoxy)phenyl]-1H-pyrazol-3-::US10577360, Example 103	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432239&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584929	438641179							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877009	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(OC(F)(F)F)c1	InChI=1S/C21H21F3N4O2S/c1-26-10-7-15(8-11-26)28(20(29)18-6-3-13-31-18)19-9-12-27(25-19)16-4-2-5-17(14-16)30-21(22,23)24/h2-6,9,12-15H,7-8,10-11H2,1H3	NVSATIAIGKWSAX-UHFFFAOYSA-N	432239	N-(1-Methylpiperidin-4-yl)-N-{1-[3-(trifluoromethoxy)phenyl]-1H-pyrazol-3-::US10577360, Example 103	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432239&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584929	438641179							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877010	COc1cc(F)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23FN4O2S/c1-24-8-5-16(6-9-24)26(21(27)19-4-3-11-29-19)20-7-10-25(23-20)17-12-15(22)13-18(14-17)28-2/h3-4,7,10-14,16H,5-6,8-9H2,1-2H3	LRDBTLRFYYQSHO-UHFFFAOYSA-N	432241	N-[1-(3-Fluoro-5-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 104	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432241&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036025	438641181							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877011	COc1cc(F)cc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23FN4O2S/c1-24-8-5-16(6-9-24)26(21(27)19-4-3-11-29-19)20-7-10-25(23-20)17-12-15(22)13-18(14-17)28-2/h3-4,7,10-14,16H,5-6,8-9H2,1-2H3	LRDBTLRFYYQSHO-UHFFFAOYSA-N	432241	N-[1-(3-Fluoro-5-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 104	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432241&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036025	438641181							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877012	COc1cc(ccn1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C20H23N5O2S/c1-23-10-6-15(7-11-23)25(20(26)17-4-3-13-28-17)18-8-12-24(22-18)16-5-9-21-19(14-16)27-2/h3-5,8-9,12-15H,6-7,10-11H2,1-2H3	STJHPTBGVAJNNB-UHFFFAOYSA-N	432242	N-[1-(2-Methoxypyridin-4-yl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 105	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432242&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585095	438641182							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877013	COc1cc(ccn1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C20H23N5O2S/c1-23-10-6-15(7-11-23)25(20(26)17-4-3-13-28-17)18-8-12-24(22-18)16-5-9-21-19(14-16)27-2/h3-5,8-9,12-15H,6-7,10-11H2,1-2H3	STJHPTBGVAJNNB-UHFFFAOYSA-N	432242	N-[1-(2-Methoxypyridin-4-yl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 105	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432242&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585095	438641182							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877014	CN(C)c1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H27N5OS/c1-24(2)18-6-4-7-19(16-18)26-14-11-21(23-26)27(17-9-12-25(3)13-10-17)22(28)20-8-5-15-29-20/h4-8,11,14-17H,9-10,12-13H2,1-3H3	JGBZMNXEGLVKET-UHFFFAOYSA-N	432243	N-{1-[3-(Dimethylamino)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-::US10577360, Example 106	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432243&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036023	438641183							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877015	CN(C)c1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C22H27N5OS/c1-24(2)18-6-4-7-19(16-18)26-14-11-21(23-26)27(17-9-12-25(3)13-10-17)22(28)20-8-5-15-29-20/h4-8,11,14-17H,9-10,12-13H2,1-3H3	JGBZMNXEGLVKET-UHFFFAOYSA-N	432243	N-{1-[3-(Dimethylamino)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-::US10577360, Example 106	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432243&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036023	438641183							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877016	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(NC(C)=O)c1	InChI=1S/C22H25N5O2S/c1-16(28)23-17-5-3-6-19(15-17)26-13-10-21(24-26)27(18-8-11-25(2)12-9-18)22(29)20-7-4-14-30-20/h3-7,10,13-15,18H,8-9,11-12H2,1-2H3,(H,23,28)	JABIPFOKSVATKT-UHFFFAOYSA-N	432244	N-[1-(3-Acetamidophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 107	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432244&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036030	438641184							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877017	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(NC(C)=O)c1	InChI=1S/C22H25N5O2S/c1-16(28)23-17-5-3-6-19(15-17)26-13-10-21(24-26)27(18-8-11-25(2)12-9-18)22(29)20-7-4-14-30-20/h3-7,10,13-15,18H,8-9,11-12H2,1-2H3,(H,23,28)	JABIPFOKSVATKT-UHFFFAOYSA-N	432244	N-[1-(3-Acetamidophenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 107	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432244&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036030	438641184							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877018	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(NS(C)(=O)=O)c1	InChI=1S/C21H25N5O3S2/c1-24-11-8-17(9-12-24)26(21(27)19-7-4-14-30-19)20-10-13-25(22-20)18-6-3-5-16(15-18)23-31(2,28)29/h3-7,10,13-15,17,23H,8-9,11-12H2,1-2H3	FDPVBCZXWZOGLC-UHFFFAOYSA-N	432245	N-(1-Methylpiperidin-4-yl)-N-{1-[3-(methylsulfonamido)phenyl]-1H-pyrazol-3-::US10577360, Example 108	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432245&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584986	438641185							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877019	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(NS(C)(=O)=O)c1	InChI=1S/C21H25N5O3S2/c1-24-11-8-17(9-12-24)26(21(27)19-7-4-14-30-19)20-10-13-25(22-20)18-6-3-5-16(15-18)23-31(2,28)29/h3-7,10,13-15,17,23H,8-9,11-12H2,1-2H3	FDPVBCZXWZOGLC-UHFFFAOYSA-N	432245	N-(1-Methylpiperidin-4-yl)-N-{1-[3-(methylsulfonamido)phenyl]-1H-pyrazol-3-::US10577360, Example 108	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432245&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584986	438641185							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877020	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccnn1C	InChI=1S/C18H22N6OS/c1-21-10-6-14(7-11-21)24(18(25)15-4-3-13-26-15)16-8-12-23(20-16)17-5-9-19-22(17)2/h3-5,8-9,12-14H,6-7,10-11H2,1-2H3	NCATXMNSPSJBRI-UHFFFAOYSA-N	432246	N-(2'-Methyl-2'H-[1,3'-bipyrazol]-3-yl)-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 109	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432246&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585138	438641186							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877021	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccnn1C	InChI=1S/C18H22N6OS/c1-21-10-6-14(7-11-21)24(18(25)15-4-3-13-26-15)16-8-12-23(20-16)17-5-9-19-22(17)2/h3-5,8-9,12-14H,6-7,10-11H2,1-2H3	NCATXMNSPSJBRI-UHFFFAOYSA-N	432246	N-(2'-Methyl-2'H-[1,3'-bipyrazol]-3-yl)-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 109	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432246&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585138	438641186							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877022	COc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1ccsc1	InChI=1S/C21H24N4O2S/c1-23-10-6-17(7-11-23)25(21(26)16-9-13-28-15-16)20-8-12-24(22-20)18-4-3-5-19(14-18)27-2/h3-5,8-9,12-15,17H,6-7,10-11H2,1-2H3	BUULYULMRXVJCA-UHFFFAOYSA-N	432247	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-3-::US10577360, Example 110	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432247&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036036	438641187							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877023	COc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1ccsc1	InChI=1S/C21H24N4O2S/c1-23-10-6-17(7-11-23)25(21(26)16-9-13-28-15-16)20-8-12-24(22-20)18-4-3-5-19(14-18)27-2/h3-5,8-9,12-15,17H,6-7,10-11H2,1-2H3	BUULYULMRXVJCA-UHFFFAOYSA-N	432247	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-3-::US10577360, Example 110	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432247&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036036	438641187							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877024	COc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccc(O)c1	InChI=1S/C23H26N4O3/c1-25-12-9-18(10-13-25)27(23(29)17-5-3-7-20(28)15-17)22-11-14-26(24-22)19-6-4-8-21(16-19)30-2/h3-8,11,14-16,18,28H,9-10,12-13H2,1-2H3	KGYTWKJBVJGHDW-UHFFFAOYSA-N	432248	3-Hydroxy-N-[1-(3-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 111	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432248&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036032	438641188							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877025	COc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccc(O)c1	InChI=1S/C23H26N4O3/c1-25-12-9-18(10-13-25)27(23(29)17-5-3-7-20(28)15-17)22-11-14-26(24-22)19-6-4-8-21(16-19)30-2/h3-8,11,14-16,18,28H,9-10,12-13H2,1-2H3	KGYTWKJBVJGHDW-UHFFFAOYSA-N	432248	3-Hydroxy-N-[1-(3-methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 111	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432248&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036032	438641188							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877026	COc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H24N4O2S/c1-23-11-8-16(9-12-23)25(21(26)19-7-4-14-28-19)20-10-13-24(22-20)17-5-3-6-18(15-17)27-2/h3-7,10,13-16H,8-9,11-12H2,1-2H3	HKJZUAMATDPBNB-UHFFFAOYSA-N	432249	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 112	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432249&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035763	438641189							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877027	COc1cccc(c1)-n1ccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H24N4O2S/c1-23-11-8-16(9-12-23)25(21(26)19-7-4-14-28-19)20-10-13-24(22-20)17-5-3-6-18(15-17)27-2/h3-7,10,13-16H,8-9,11-12H2,1-2H3	HKJZUAMATDPBNB-UHFFFAOYSA-N	432249	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 112	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432249&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035763	438641189							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877028	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C23H24N6O2S/c1-16-24-25-22(31-16)17-5-3-6-19(15-17)28-13-10-21(26-28)29(18-8-11-27(2)12-9-18)23(30)20-7-4-14-32-20/h3-7,10,13-15,18H,8-9,11-12H2,1-2H3	DHFJNTIKYWMGTR-UHFFFAOYSA-N	432250	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-::US10577360, Example 113	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432250&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585055	438641190							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877029	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C23H24N6O2S/c1-16-24-25-22(31-16)17-5-3-6-19(15-17)28-13-10-21(26-28)29(18-8-11-27(2)12-9-18)23(30)20-7-4-14-32-20/h3-7,10,13-15,18H,8-9,11-12H2,1-2H3	DHFJNTIKYWMGTR-UHFFFAOYSA-N	432250	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-::US10577360, Example 113	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	<100								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432250&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585055	438641190							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877030	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(O)c1	InChI=1S/C20H22N4O2S/c1-22-10-7-15(8-11-22)24(20(26)18-6-3-13-27-18)19-9-12-23(21-19)16-4-2-5-17(25)14-16/h2-6,9,12-15,25H,7-8,10-11H2,1H3	SVMJQAXDZOZTOT-UHFFFAOYSA-N	432251	N-[1-(3-Hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 114	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432251&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585067	438641191							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877031	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(O)c1	InChI=1S/C20H22N4O2S/c1-22-10-7-15(8-11-22)24(20(26)18-6-3-13-27-18)19-9-12-23(21-19)16-4-2-5-17(25)14-16/h2-6,9,12-15,25H,7-8,10-11H2,1H3	SVMJQAXDZOZTOT-UHFFFAOYSA-N	432251	N-[1-(3-Hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 114	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432251&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585067	438641191							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877032	CN1CCC(CC1)N(C(=O)c1cccs1)c1cc(C)n(n1)-c1ccccc1	InChI=1S/C21H24N4OS/c1-16-15-20(22-25(16)18-7-4-3-5-8-18)24(17-10-12-23(2)13-11-17)21(26)19-9-6-14-27-19/h3-9,14-15,17H,10-13H2,1-2H3	VGDXRJYDQQCBJC-UHFFFAOYSA-N	432252	N-(5-Methyl-1-phenyl-1H-pyrazol-3-yl)-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 115	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432252&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035759	438641192							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877033	CN1CCC(CC1)N(C(=O)c1cccs1)c1cc(C)n(n1)-c1ccccc1	InChI=1S/C21H24N4OS/c1-16-15-20(22-25(16)18-7-4-3-5-8-18)24(17-10-12-23(2)13-11-17)21(26)19-9-6-14-27-19/h3-9,14-15,17H,10-13H2,1-2H3	VGDXRJYDQQCBJC-UHFFFAOYSA-N	432252	N-(5-Methyl-1-phenyl-1H-pyrazol-3-yl)-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 115	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432252&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035759	438641192							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877034	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccc(cc1)C#N)c1cccs1	InChI=1S/C27H25N5OS/c28-19-21-8-10-23(11-9-21)31-17-14-26(29-31)32(27(33)25-7-4-18-34-25)24-12-15-30(16-13-24)20-22-5-2-1-3-6-22/h1-11,14,17-18,24H,12-13,15-16,20H2	FFESVDVMNDHNSC-UHFFFAOYSA-N	432253	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-cyanophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 116	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432253&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035762	438641193							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877035	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1ccc(cc1)C#N)c1cccs1	InChI=1S/C27H25N5OS/c28-19-21-8-10-23(11-9-21)31-17-14-26(29-31)32(27(33)25-7-4-18-34-25)24-12-15-30(16-13-24)20-22-5-2-1-3-6-22/h1-11,14,17-18,24H,12-13,15-16,20H2	FFESVDVMNDHNSC-UHFFFAOYSA-N	432253	N-(1-Benzylpiperidin-4-yl)-N-[1-(4-cyanophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 116	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432253&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035762	438641193							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877036	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1cccc(c1)C#N)c1cccs1	InChI=1S/C27H25N5OS/c28-19-22-8-4-9-24(18-22)31-16-13-26(29-31)32(27(33)25-10-5-17-34-25)23-11-14-30(15-12-23)20-21-6-2-1-3-7-21/h1-10,13,16-18,23H,11-12,14-15,20H2	ADKVRDHNDSYPNT-UHFFFAOYSA-N	432254	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-cyanophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 117	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432254&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036163	438641194							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877037	O=C(N(C1CCN(Cc2ccccc2)CC1)c1ccn(n1)-c1cccc(c1)C#N)c1cccs1	InChI=1S/C27H25N5OS/c28-19-22-8-4-9-24(18-22)31-16-13-26(29-31)32(27(33)25-10-5-17-34-25)23-11-14-30(15-12-23)20-21-6-2-1-3-7-21/h1-10,13,16-18,23H,11-12,14-15,20H2	ADKVRDHNDSYPNT-UHFFFAOYSA-N	432254	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-cyanophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 117	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432254&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036163	438641194							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877038	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C29H28N6O2S/c1-21-30-31-28(37-21)23-9-5-10-25(19-23)34-17-14-27(32-34)35(29(36)26-11-6-18-38-26)24-12-15-33(16-13-24)20-22-7-3-2-4-8-22/h2-11,14,17-19,24H,12-13,15-16,20H2,1H3	IFBXKMUEWNXRBD-UHFFFAOYSA-N	432255	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 118	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432255&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010092	438641195							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877039	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C29H28N6O2S/c1-21-30-31-28(37-21)23-9-5-10-25(19-23)34-17-14-27(32-34)35(29(36)26-11-6-18-38-26)24-12-15-33(16-13-24)20-22-7-3-2-4-8-22/h2-11,14,17-19,24H,12-13,15-16,20H2,1H3	IFBXKMUEWNXRBD-UHFFFAOYSA-N	432255	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 118	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432255&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010092	438641195							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877040	Fc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C26H25FN4OS/c27-21-8-4-9-23(18-21)30-16-13-25(28-30)31(26(32)24-10-5-17-33-24)22-11-14-29(15-12-22)19-20-6-2-1-3-7-20/h1-10,13,16-18,22H,11-12,14-15,19H2	JNZGMMNFBMGQSA-UHFFFAOYSA-N	432256	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-fluorophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 119	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432256&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036168	438641196							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877041	Fc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C26H25FN4OS/c27-21-8-4-9-23(18-21)30-16-13-25(28-30)31(26(32)24-10-5-17-33-24)22-11-14-29(15-12-22)19-20-6-2-1-3-7-20/h1-10,13,16-18,22H,11-12,14-15,19H2	JNZGMMNFBMGQSA-UHFFFAOYSA-N	432256	N-(1-Benzylpiperidin-4-yl)-N-[1-(3-fluorophenyl)-1H-pyrazol-3-yl]thiophene-2-::US10577360, Example 119	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432256&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036168	438641196							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877042	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccco1	InChI=1S/C29H28N6O3/c1-21-30-31-28(38-21)23-9-5-10-25(19-23)34-17-14-27(32-34)35(29(36)26-11-6-18-37-26)24-12-15-33(16-13-24)20-22-7-3-2-4-8-22/h2-11,14,17-19,24H,12-13,15-16,20H2,1H3	KUNVNGITISMAJS-UHFFFAOYSA-N	432257	N-(1-Benzylpiperidin-4-yl)-N-{1-3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 120	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432257&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036171	438641197							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877043	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccco1	InChI=1S/C29H28N6O3/c1-21-30-31-28(38-21)23-9-5-10-25(19-23)34-17-14-27(32-34)35(29(36)26-11-6-18-37-26)24-12-15-33(16-13-24)20-22-7-3-2-4-8-22/h2-11,14,17-19,24H,12-13,15-16,20H2,1H3	KUNVNGITISMAJS-UHFFFAOYSA-N	432257	N-(1-Benzylpiperidin-4-yl)-N-{1-3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 120	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432257&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036171	438641197							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877044	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccn2)CC1)C(=O)c1cccs1	InChI=1S/C26H27N5O2S/c1-33-23-8-4-7-22(18-23)30-16-12-25(28-30)31(26(32)24-9-5-17-34-24)21-10-14-29(15-11-21)19-20-6-2-3-13-27-20/h2-9,12-13,16-18,21H,10-11,14-15,19H2,1H3	WIOHNFFKAFAJLM-UHFFFAOYSA-N	432258	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-(pyridin-2-ylmethyl)piperidin-4-::US10577360, Example 121	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432258&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036166	438641198							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877045	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccccn2)CC1)C(=O)c1cccs1	InChI=1S/C26H27N5O2S/c1-33-23-8-4-7-22(18-23)30-16-12-25(28-30)31(26(32)24-9-5-17-34-24)21-10-14-29(15-11-21)19-20-6-2-3-13-27-20/h2-9,12-13,16-18,21H,10-11,14-15,19H2,1H3	WIOHNFFKAFAJLM-UHFFFAOYSA-N	432258	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-(pyridin-2-ylmethyl)piperidin-4-::US10577360, Example 121	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432258&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036166	438641198							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877046	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccc(nc2)C(F)(F)F)CC1)C(=O)c1cccs1	InChI=1S/C27H26F3N5O2S/c1-37-22-5-2-4-21(16-22)34-14-11-25(32-34)35(26(36)23-6-3-15-38-23)20-9-12-33(13-10-20)18-19-7-8-24(31-17-19)27(28,29)30/h2-8,11,14-17,20H,9-10,12-13,18H2,1H3	PGWIWSARRRCBLV-UHFFFAOYSA-N	432259	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-{[6-(trifluoromethyl)pyridin-3-::US10577360, Example 122	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432259&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036164	438641199							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877047	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2ccc(nc2)C(F)(F)F)CC1)C(=O)c1cccs1	InChI=1S/C27H26F3N5O2S/c1-37-22-5-2-4-21(16-22)34-14-11-25(32-34)35(26(36)23-6-3-15-38-23)20-9-12-33(13-10-20)18-19-7-8-24(31-17-19)27(28,29)30/h2-8,11,14-17,20H,9-10,12-13,18H2,1H3	PGWIWSARRRCBLV-UHFFFAOYSA-N	432259	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-[1-{[6-(trifluoromethyl)pyridin-3-::US10577360, Example 122	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432259&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036164	438641199							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877048	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(O)cc1Cl	InChI=1S/C20H21ClN4O2S/c1-23-9-6-14(7-10-23)25(20(27)18-3-2-12-28-18)19-8-11-24(22-19)17-5-4-15(26)13-16(17)21/h2-5,8,11-14,26H,6-7,9-10H2,1H3	OMIDTTVZNSEVCQ-UHFFFAOYSA-N	432260	N-[1-(2-Chloro-4-hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 123	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432260&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010577	438641200							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877049	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(O)cc1Cl	InChI=1S/C20H21ClN4O2S/c1-23-9-6-14(7-10-23)25(20(27)18-3-2-12-28-18)19-8-11-24(22-19)17-5-4-15(26)13-16(17)21/h2-5,8,11-14,26H,6-7,9-10H2,1H3	OMIDTTVZNSEVCQ-UHFFFAOYSA-N	432260	N-[1-(2-Chloro-4-hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 123	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432260&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010577	438641200							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877050	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(F)c(O)c1	InChI=1S/C20H21FN4O2S/c1-23-9-6-14(7-10-23)25(20(27)18-3-2-12-28-18)19-8-11-24(22-19)15-4-5-16(21)17(26)13-15/h2-5,8,11-14,26H,6-7,9-10H2,1H3	JOVCVHIELRFESK-UHFFFAOYSA-N	432261	N-[1-(4-Fluoro-3-hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 124	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432261&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035915	438641201							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877051	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccc(F)c(O)c1	InChI=1S/C20H21FN4O2S/c1-23-9-6-14(7-10-23)25(20(27)18-3-2-12-28-18)19-8-11-24(22-19)15-4-5-16(21)17(26)13-15/h2-5,8,11-14,26H,6-7,9-10H2,1H3	JOVCVHIELRFESK-UHFFFAOYSA-N	432261	N-[1-(4-Fluoro-3-hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 124	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432261&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035915	438641201							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877052	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cc(O)ccc1Cl	InChI=1S/C20H21ClN4O2S/c1-23-9-6-14(7-10-23)25(20(27)18-3-2-12-28-18)19-8-11-24(22-19)17-13-15(26)4-5-16(17)21/h2-5,8,11-14,26H,6-7,9-10H2,1H3	XYVWZYFSYBZOOY-UHFFFAOYSA-N	432262	N-[1-(2-Chloro-5-hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 125	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432262&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035916	438641202							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877053	CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cc(O)ccc1Cl	InChI=1S/C20H21ClN4O2S/c1-23-9-6-14(7-10-23)25(20(27)18-3-2-12-28-18)19-8-11-24(22-19)17-13-15(26)4-5-16(17)21/h2-5,8,11-14,26H,6-7,9-10H2,1H3	XYVWZYFSYBZOOY-UHFFFAOYSA-N	432262	N-[1-(2-Chloro-5-hydroxyphenyl)-1H-pyrazol-3-yl]-N-(1-methylpiperidin-4-::US10577360, Example 125	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432262&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035916	438641202							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877054	CC(C)CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H30N6O2S/c1-18(2)17-30-12-9-21(10-13-30)32(26(33)23-8-5-15-35-23)24-11-14-31(29-24)22-7-4-6-20(16-22)25-28-27-19(3)34-25/h4-8,11,14-16,18,21H,9-10,12-13,17H2,1-3H3	LQNHKTSWWATWLK-UHFFFAOYSA-N	432263	N-(1-Isobutylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 126	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432263&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035760	438641203							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877055	CC(C)CN1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H30N6O2S/c1-18(2)17-30-12-9-21(10-13-30)32(26(33)23-8-5-15-35-23)24-11-14-31(29-24)22-7-4-6-20(16-22)25-28-27-19(3)34-25/h4-8,11,14-16,18,21H,9-10,12-13,17H2,1-3H3	LQNHKTSWWATWLK-UHFFFAOYSA-N	432263	N-(1-Isobutylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-::US10577360, Example 126	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432263&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035760	438641203							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877056	CN(C)C1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H26N4OS/c1-24(2)17-10-12-19(13-11-17)26(22(27)20-9-6-16-28-20)21-14-15-25(23-21)18-7-4-3-5-8-18/h3-9,14-17,19H,10-13H2,1-2H3	VJFCLLJGDUZGJV-UHFFFAOYSA-N	432264	N-[4-(Dimethylamino)cyclohexyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 127	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432264&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010321	438641204							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877057	CN(C)C1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C22H26N4OS/c1-24(2)17-10-12-19(13-11-17)26(22(27)20-9-6-16-28-20)21-14-15-25(23-21)18-7-4-3-5-8-18/h3-9,14-17,19H,10-13H2,1-2H3	VJFCLLJGDUZGJV-UHFFFAOYSA-N	432264	N-[4-(Dimethylamino)cyclohexyl]-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 127	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432264&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010321	438641204							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877058	CN(Cc1ccccc1)C1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C28H30N4OS/c1-30(21-22-9-4-2-5-10-22)23-14-16-25(17-15-23)32(28(33)26-13-8-20-34-26)27-18-19-31(29-27)24-11-6-3-7-12-24/h2-13,18-20,23,25H,14-17,21H2,1H3	HISPOVTVDINSRQ-UHFFFAOYSA-N	432265	N-{4-[Benzyl(methyl)amino]cyclohexyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 128	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432265&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585114	438641205							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877059	CN(Cc1ccccc1)C1CCC(CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1ccccc1	InChI=1S/C28H30N4OS/c1-30(21-22-9-4-2-5-10-22)23-14-16-25(17-15-23)32(28(33)26-13-8-20-34-26)27-18-19-31(29-27)24-11-6-3-7-12-24/h2-13,18-20,23,25H,14-17,21H2,1H3	HISPOVTVDINSRQ-UHFFFAOYSA-N	432265	N-{4-[Benzyl(methyl)amino]cyclohexyl}-N-(1-phenyl-1H-pyrazol-3-yl)thiophene-2-::US10577360, Example 128	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432265&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585114	438641205							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877060	CN1CCC(CC1)N(C(=O)c1cccs1)c1cccc(n1)-c1ccc(F)cc1	InChI=1S/C22H22FN3OS/c1-25-13-11-18(12-14-25)26(22(27)20-5-3-15-28-20)21-6-2-4-19(24-21)16-7-9-17(23)10-8-16/h2-10,15,18H,11-14H2,1H3	FHJBELMHYSMBBQ-UHFFFAOYSA-N	432266	N-[6-(4-Fluorophenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 129	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432266&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010189	438641206							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877061	CN1CCC(CC1)N(C(=O)c1cccs1)c1cccc(n1)-c1ccc(F)cc1	InChI=1S/C22H22FN3OS/c1-25-13-11-18(12-14-25)26(22(27)20-5-3-15-28-20)21-6-2-4-19(24-21)16-7-9-17(23)10-8-16/h2-10,15,18H,11-14H2,1H3	FHJBELMHYSMBBQ-UHFFFAOYSA-N	432266	N-[6-(4-Fluorophenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 129	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432266&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010189	438641206							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877062	CN1CCC(CC1)N(C(=O)c1cccs1)c1cccc(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H25N5O2S/c1-17-27-28-24(32-17)19-7-3-6-18(16-19)21-8-4-10-23(26-21)30(20-11-13-29(2)14-12-20)25(31)22-9-5-15-33-22/h3-10,15-16,20H,11-14H2,1-2H3	IXQDBAZLIFALFX-UHFFFAOYSA-N	432267	N-{6-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]pyridin-2-yl]-N-(1-methylpiperidin-4-::US10577360, Example 130	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432267&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036347	438641207							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877063	CN1CCC(CC1)N(C(=O)c1cccs1)c1cccc(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H25N5O2S/c1-17-27-28-24(32-17)19-7-3-6-18(16-19)21-8-4-10-23(26-21)30(20-11-13-29(2)14-12-20)25(31)22-9-5-15-33-22/h3-10,15-16,20H,11-14H2,1-2H3	IXQDBAZLIFALFX-UHFFFAOYSA-N	432267	N-{6-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]pyridin-2-yl]-N-(1-methylpiperidin-4-::US10577360, Example 130	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 300								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432267&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036347	438641207							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877064	COc1cccc(c1)-c1cccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C23H25N3O2S/c1-25-13-11-18(12-14-25)26(23(27)21-9-5-15-29-21)22-10-4-8-20(24-22)17-6-3-7-19(16-17)28-2/h3-10,15-16,18H,11-14H2,1-2H3	DEHYWOBDGOLXFQ-UHFFFAOYSA-N	432268	N-[6-(3-Methoxyphenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 131	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432268&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036355	438641208							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877065	COc1cccc(c1)-c1cccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C23H25N3O2S/c1-25-13-11-18(12-14-25)26(23(27)21-9-5-15-29-21)22-10-4-8-20(24-22)17-6-3-7-19(16-17)28-2/h3-10,15-16,18H,11-14H2,1-2H3	DEHYWOBDGOLXFQ-UHFFFAOYSA-N	432268	N-[6-(3-Methoxyphenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 131	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432268&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036355	438641208							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877066	COc1ccc(cc1)-c1cccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C23H25N3O2S/c1-25-14-12-18(13-15-25)26(23(27)21-6-4-16-29-21)22-7-3-5-20(24-22)17-8-10-19(28-2)11-9-17/h3-11,16,18H,12-15H2,1-2H3	JMFRWIXBZRDEAX-UHFFFAOYSA-N	432269	N-[6-(4-Methoxyphenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 132	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432269&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036350	438641209							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877067	COc1ccc(cc1)-c1cccc(n1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C23H25N3O2S/c1-25-14-12-18(13-15-25)26(23(27)21-6-4-16-29-21)22-7-3-5-20(24-22)17-8-10-19(28-2)11-9-17/h3-11,16,18H,12-15H2,1-2H3	JMFRWIXBZRDEAX-UHFFFAOYSA-N	432269	N-[6-(4-Methoxyphenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 132	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432269&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036350	438641209							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877068	Fc1ccc(cc1)-c1cncc(n1)N(C1CCNCC1)C(=O)c1cccs1	InChI=1S/C20H19FN4OS/c21-15-5-3-14(4-6-15)17-12-23-13-19(24-17)25(16-7-9-22-10-8-16)20(26)18-2-1-11-27-18/h1-6,11-13,16,22H,7-10H2	DGBCNEFEGSLUID-UHFFFAOYSA-N	432270	N-[6-(4-Fluorophenyl)pyrazin-2-yl]-N-(piperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 133	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432270&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010424	438641210							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877069	Fc1ccc(cc1)-c1cncc(n1)N(C1CCNCC1)C(=O)c1cccs1	InChI=1S/C20H19FN4OS/c21-15-5-3-14(4-6-15)17-12-23-13-19(24-17)25(16-7-9-22-10-8-16)20(26)18-2-1-11-27-18/h1-6,11-13,16,22H,7-10H2	DGBCNEFEGSLUID-UHFFFAOYSA-N	432270	N-[6-(4-Fluorophenyl)pyrazin-2-yl]-N-(piperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 133	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432270&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010424	438641210							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877070	CN1CCC(CC1)N(C(=O)c1cccs1)c1cncc(n1)-c1ccc(F)cc1	InChI=1S/C21H21FN4OS/c1-25-10-8-17(9-11-25)26(21(27)19-3-2-12-28-19)20-14-23-13-18(24-20)15-4-6-16(22)7-5-15/h2-7,12-14,17H,8-11H2,1H3	MASRFTKDHNMURD-UHFFFAOYSA-N	432271	N-[6-(4-Fluorophenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 134	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432271&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010663	438641211							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877071	CN1CCC(CC1)N(C(=O)c1cccs1)c1cncc(n1)-c1ccc(F)cc1	InChI=1S/C21H21FN4OS/c1-25-10-8-17(9-11-25)26(21(27)19-3-2-12-28-19)20-14-23-13-18(24-20)15-4-6-16(22)7-5-15/h2-7,12-14,17H,8-11H2,1H3	MASRFTKDHNMURD-UHFFFAOYSA-N	432271	N-[6-(4-Fluorophenyl)pyrazin-2-yl]-N-(1-methylpiperidin-4-yl)thiophene-2-::US10577360, Example 134	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432271&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010663	438641211							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877072	Fc1ccc(cc1)-n1cc(nn1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H24FN5OS/c26-20-8-10-21(11-9-20)30-18-24(27-28-30)31(25(32)23-7-4-16-33-23)22-12-14-29(15-13-22)17-19-5-2-1-3-6-19/h1-11,16,18,22H,12-15,17H2	DCDFUOOSBBEXIP-UHFFFAOYSA-N	432272	N-(1-benzylpiperidin-4-yl)-N-(1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl)thiophene-2-::US10577360, Example 135	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432272&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035781	438641212							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877073	Fc1ccc(cc1)-n1cc(nn1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C25H24FN5OS/c26-20-8-10-21(11-9-20)30-18-24(27-28-30)31(25(32)23-7-4-16-33-23)22-12-14-29(15-13-22)17-19-5-2-1-3-6-19/h1-11,16,18,22H,12-15,17H2	DCDFUOOSBBEXIP-UHFFFAOYSA-N	432272	N-(1-benzylpiperidin-4-yl)-N-(1-(4-fluorophenyl)-1H-1,2,3-triazol-4-yl)thiophene-2-::US10577360, Example 135	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432272&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035781	438641212							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877074	O=C(N(C1CCN(Cc2ccccc2)CC1)c1cn(nn1)-c1ccccc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-12-7-17-32-23)30(24-19-29(27-26-24)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	MKXVLTLTANCGBG-UHFFFAOYSA-N	432273	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,3-triazol-4-yl)thiophene-2-::US10577360, Example 136::US10577360, Example 137	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432273&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036104	438641213							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877075	O=C(N(C1CCN(Cc2ccccc2)CC1)c1cn(nn1)-c1ccccc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-12-7-17-32-23)30(24-19-29(27-26-24)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	MKXVLTLTANCGBG-UHFFFAOYSA-N	432273	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,3-triazol-4-yl)thiophene-2-::US10577360, Example 136::US10577360, Example 137	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432273&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036104	438641213							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877076	O=C(N(C1CCN(Cc2ccccc2)CC1)c1cn(nn1)-c1ccccc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-12-7-17-32-23)30(24-19-29(27-26-24)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	MKXVLTLTANCGBG-UHFFFAOYSA-N	432273	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,3-triazol-4-yl)thiophene-2-::US10577360, Example 136::US10577360, Example 137	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432273&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036104	438641213							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877077	O=C(N(C1CCN(Cc2ccccc2)CC1)c1cn(nn1)-c1ccccc1)c1cccs1	InChI=1S/C25H25N5OS/c31-25(23-12-7-17-32-23)30(24-19-29(27-26-24)21-10-5-2-6-11-21)22-13-15-28(16-14-22)18-20-8-3-1-4-9-20/h1-12,17,19,22H,13-16,18H2	MKXVLTLTANCGBG-UHFFFAOYSA-N	432273	N-(1-benzylpiperidin-4-yl)-N-(1-phenyl-1H-1,2,3-triazol-4-yl)thiophene-2-::US10577360, Example 136::US10577360, Example 137	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432273&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036104	438641213							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877078	COc1cccc(c1)C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H28N6O3/c1-18-27-28-25(35-18)19-6-4-8-22(16-19)31-15-12-24(29-31)32(21-10-13-30(2)14-11-21)26(33)20-7-5-9-23(17-20)34-3/h4-9,12,15-17,21H,10-11,13-14H2,1-3H3	QCPMFNYNNADDEN-UHFFFAOYSA-N	432275	3-Methoxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 138	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432275&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585047	438641214							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877079	COc1cccc(c1)C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H28N6O3/c1-18-27-28-25(35-18)19-6-4-8-22(16-19)31-15-12-24(29-31)32(21-10-13-30(2)14-11-21)26(33)20-7-5-9-23(17-20)34-3/h4-9,12,15-17,21H,10-11,13-14H2,1-3H3	QCPMFNYNNADDEN-UHFFFAOYSA-N	432275	3-Methoxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 138	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432275&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585047	438641214							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877080	CCOc1cccc(c1)C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C27H30N6O3/c1-4-35-24-10-6-8-21(18-24)27(34)33(22-11-14-31(3)15-12-22)25-13-16-32(30-25)23-9-5-7-20(17-23)26-29-28-19(2)36-26/h5-10,13,16-18,22H,4,11-12,14-15H2,1-3H3	FEKHPBGSSKMMSP-UHFFFAOYSA-N	432276	3-Ethoxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 139	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432276&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585168	438641215							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877081	CCOc1cccc(c1)C(=O)N(C1CCN(C)CC1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C27H30N6O3/c1-4-35-24-10-6-8-21(18-24)27(34)33(22-11-14-31(3)15-12-22)25-13-16-32(30-25)23-9-5-7-20(17-23)26-29-28-19(2)36-26/h5-10,13,16-18,22H,4,11-12,14-15H2,1-3H3	FEKHPBGSSKMMSP-UHFFFAOYSA-N	432276	3-Ethoxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 139	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432276&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585168	438641215							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877082	CN1CCC(CC1)N(C(=O)c1ccc(O)cc1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H26N6O3/c1-17-26-27-24(34-17)19-4-3-5-21(16-19)30-15-12-23(28-30)31(20-10-13-29(2)14-11-20)25(33)18-6-8-22(32)9-7-18/h3-9,12,15-16,20,32H,10-11,13-14H2,1-2H3	BFRPJXQVNWMCCZ-UHFFFAOYSA-N	432277	4-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 140	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432277&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584907	438641216							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877083	CN1CCC(CC1)N(C(=O)c1ccc(O)cc1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H26N6O3/c1-17-26-27-24(34-17)19-4-3-5-21(16-19)30-15-12-23(28-30)31(20-10-13-29(2)14-11-20)25(33)18-6-8-22(32)9-7-18/h3-9,12,15-16,20,32H,10-11,13-14H2,1-2H3	BFRPJXQVNWMCCZ-UHFFFAOYSA-N	432277	4-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 140	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432277&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584907	438641216							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877084	CN1CCC(CC1)N(C(=O)c1cccc(c1)-c1ncc[nH]1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C28H28N8O2/c1-19-31-32-27(38-19)21-6-4-8-24(18-21)35-16-11-25(33-35)36(23-9-14-34(2)15-10-23)28(37)22-7-3-5-20(17-22)26-29-12-13-30-26/h3-8,11-13,16-18,23H,9-10,14-15H2,1-2H3,(H,29,30)	KJHPEJCNBGNXLN-UHFFFAOYSA-N	432278	3-(1H-Imidazol-2-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2- yl)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-4- yl)benzamide::US10577360, Example 141	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432278&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035950	438641217							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877085	CN1CCC(CC1)N(C(=O)c1cccc(c1)-c1ncc[nH]1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C28H28N8O2/c1-19-31-32-27(38-19)21-6-4-8-24(18-21)35-16-11-25(33-35)36(23-9-14-34(2)15-10-23)28(37)22-7-3-5-20(17-22)26-29-12-13-30-26/h3-8,11-13,16-18,23H,9-10,14-15H2,1-2H3,(H,29,30)	KJHPEJCNBGNXLN-UHFFFAOYSA-N	432278	3-(1H-Imidazol-2-yl)-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2- yl)phenyl]-1H-pyrazol-3-yl}-N-(1-methylpiperidin-4- yl)benzamide::US10577360, Example 141	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432278&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035950	438641217							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877086	CN1CCC(CC1)N(C(=O)c1cccc(NS(C)(=O)=O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H29N7O4S/c1-18-27-28-25(37-18)19-6-5-9-23(17-19)32-15-12-24(29-32)33(22-10-13-31(2)14-11-22)26(34)20-7-4-8-21(16-20)30-38(3,35)36/h4-9,12,15-17,22,30H,10-11,13-14H2,1-3H3	QRUCYVMJCWVYKC-UHFFFAOYSA-N	432279	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H- pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)-3- (methylsulfonamido)benzamide::US10577360, Example 142	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432279&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010749	438641218							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877087	CN1CCC(CC1)N(C(=O)c1cccc(NS(C)(=O)=O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H29N7O4S/c1-18-27-28-25(37-18)19-6-5-9-23(17-19)32-15-12-24(29-32)33(22-10-13-31(2)14-11-22)26(34)20-7-4-8-21(16-20)30-38(3,35)36/h4-9,12,15-17,22,30H,10-11,13-14H2,1-3H3	QRUCYVMJCWVYKC-UHFFFAOYSA-N	432279	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H- pyrazol-3-yl}-N-(1-methylpiperidin-4-yl)-3- (methylsulfonamido)benzamide::US10577360, Example 142	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432279&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010749	438641218							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877088	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCNCC1)C(=O)c1cccc(O)c1	InChI=1S/C24H24N6O3/c1-16-26-27-23(33-16)17-4-2-6-20(14-17)29-13-10-22(28-29)30(19-8-11-25-12-9-19)24(32)18-5-3-7-21(31)15-18/h2-7,10,13-15,19,25,31H,8-9,11-12H2,1H3	UICKZRQYJQEHLK-UHFFFAOYSA-N	432280	3-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(piperidin-4-yl)benzamide::US10577360, Example 143	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432280&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138605643	438641219							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877089	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCNCC1)C(=O)c1cccc(O)c1	InChI=1S/C24H24N6O3/c1-16-26-27-23(33-16)17-4-2-6-20(14-17)29-13-10-22(28-29)30(19-8-11-25-12-9-19)24(32)18-5-3-7-21(31)15-18/h2-7,10,13-15,19,25,31H,8-9,11-12H2,1H3	UICKZRQYJQEHLK-UHFFFAOYSA-N	432280	3-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-3-yl}-N-(piperidin-4-yl)benzamide::US10577360, Example 143	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432280&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138605643	438641219							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877090	C[C@H]1CC(C[C@@H](C)N1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H28N6O3/c1-16-12-22(13-17(2)27-16)32(26(34)20-7-5-9-23(33)15-20)24-10-11-31(30-24)21-8-4-6-19(14-21)25-29-28-18(3)35-25/h4-11,14-17,22,27,33H,12-13H2,1-3H3/t16-,17+,22?	CXOSALDTPGELJD-AQKKSAQBSA-N	432281	N-[(2S,6R)-2,6-Dimethylpiperidin-4-yl]-3-hydroxy-N- {1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H- pyrazol-3-yl}benzamide::US10577360, Example 144	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432281&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138584728	438641220							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877091	C[C@H]1CC(C[C@@H](C)N1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C26H28N6O3/c1-16-12-22(13-17(2)27-16)32(26(34)20-7-5-9-23(33)15-20)24-10-11-31(30-24)21-8-4-6-19(14-21)25-29-28-18(3)35-25/h4-11,14-17,22,27,33H,12-13H2,1-3H3/t16-,17+,22?	CXOSALDTPGELJD-AQKKSAQBSA-N	432281	N-[(2S,6R)-2,6-Dimethylpiperidin-4-yl]-3-hydroxy-N- {1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H- pyrazol-3-yl}benzamide::US10577360, Example 144	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432281&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138584728	438641220							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877092	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2cccc(n2)C(F)(F)F)CC1)C(=O)c1cccs1	InChI=1S/C27H26F3N5O2S/c1-37-22-7-3-6-21(17-22)34-15-12-25(32-34)35(26(36)23-8-4-16-38-23)20-10-13-33(14-11-20)18-19-5-2-9-24(31-19)27(28,29)30/h2-9,12,15-17,20H,10-11,13-14,18H2,1H3	PWFNOZHIVFXRME-UHFFFAOYSA-N	432282	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-{[6- (trifluoromethyl)pyridin-2-yl]methyl}piperidin-4-yl) thiophene-2-carboxamide::US10577360, Example 145	Mu-type opioid receptor	Homo sapiens	 300								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432282&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010006	438641221							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877093	COc1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2cccc(n2)C(F)(F)F)CC1)C(=O)c1cccs1	InChI=1S/C27H26F3N5O2S/c1-37-22-7-3-6-21(17-22)34-15-12-25(32-34)35(26(36)23-8-4-16-38-23)20-10-13-33(14-11-20)18-19-5-2-9-24(31-19)27(28,29)30/h2-9,12,15-17,20H,10-11,13-14,18H2,1H3	PWFNOZHIVFXRME-UHFFFAOYSA-N	432282	N-[1-(3-Methoxyphenyl)-1H-pyrazol-3-yl]-N-(1-{[6- (trifluoromethyl)pyridin-2-yl]methyl}piperidin-4-yl) thiophene-2-carboxamide::US10577360, Example 145	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432282&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010006	438641221							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877094	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2cccc(n2)C(F)(F)F)CC1)C(=O)c1cccs1	InChI=1S/C29H26F3N7O2S/c1-19-34-35-27(41-19)20-5-2-7-23(17-20)38-15-12-26(36-38)39(28(40)24-8-4-16-42-24)22-10-13-37(14-11-22)18-21-6-3-9-25(33-21)29(30,31)32/h2-9,12,15-17,22H,10-11,13-14,18H2,1H3	UYFQCEKOYQPFBF-UHFFFAOYSA-N	432283	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}-N-(1-{[6-(trifluoromethyl)pyridin-2-yl]methyl} piperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 146	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432283&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138605727	438641222							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877095	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(Cc2cccc(n2)C(F)(F)F)CC1)C(=O)c1cccs1	InChI=1S/C29H26F3N7O2S/c1-19-34-35-27(41-19)20-5-2-7-23(17-20)38-15-12-26(36-38)39(28(40)24-8-4-16-42-24)22-10-13-37(14-11-22)18-21-6-3-9-25(33-21)29(30,31)32/h2-9,12,15-17,22H,10-11,13-14,18H2,1H3	UYFQCEKOYQPFBF-UHFFFAOYSA-N	432283	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}-N-(1-{[6-(trifluoromethyl)pyridin-2-yl]methyl} piperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 146	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	 2750								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432283&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138605727	438641222							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877096	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(CC(O)c2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C30H30N6O3S/c1-21-31-32-29(39-21)23-9-5-10-25(19-23)35-17-14-28(33-35)36(30(38)27-11-6-18-40-27)24-12-15-34(16-13-24)20-26(37)22-7-3-2-4-8-22/h2-11,14,17-19,24,26,37H,12-13,15-16,20H2,1H3	QQMQRIPSBOXWFZ-UHFFFAOYSA-N	432284	N-[1-(2-Hydroxy-2-phenylethyl)piperidin-4-yl]-N-{1-[3- (5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3- yl}thiophene-2-carboxamide::US10577360, Example 147	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432284&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010007	438641223							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877097	Cc1nnc(o1)-c1cccc(c1)-n1ccc(n1)N(C1CCN(CC(O)c2ccccc2)CC1)C(=O)c1cccs1	InChI=1S/C30H30N6O3S/c1-21-31-32-29(39-21)23-9-5-10-25(19-23)35-17-14-28(33-35)36(30(38)27-11-6-18-40-27)24-12-15-34(16-13-24)20-26(37)22-7-3-2-4-8-22/h2-11,14,17-19,24,26,37H,12-13,15-16,20H2,1H3	QQMQRIPSBOXWFZ-UHFFFAOYSA-N	432284	N-[1-(2-Hydroxy-2-phenylethyl)piperidin-4-yl]-N-{1-[3- (5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3- yl}thiophene-2-carboxamide::US10577360, Example 147	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432284&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010007	438641223							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877098	CN(C)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H28N6O2S/c1-17-26-27-24(33-17)18-6-4-7-21(16-18)30-14-13-23(28-30)31(25(32)22-8-5-15-34-22)20-11-9-19(10-12-20)29(2)3/h4-8,13-16,19-20H,9-12H2,1-3H3/t19-,20-	SDMWEZPSBMIUBY-MXVIHJGJSA-N	432285	N-[(1r,4r)-4-(Dimethylamino)cyclohexyl]-N-{1-[3-(5- methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl} thiophene-2-carboxamide::US10577360, Example 149	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432285&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132035926	438641224							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877099	CN(C)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H28N6O2S/c1-17-26-27-24(33-17)18-6-4-7-21(16-18)30-14-13-23(28-30)31(25(32)22-8-5-15-34-22)20-11-9-19(10-12-20)29(2)3/h4-8,13-16,19-20H,9-12H2,1-3H3/t19-,20-	SDMWEZPSBMIUBY-MXVIHJGJSA-N	432285	N-[(1r,4r)-4-(Dimethylamino)cyclohexyl]-N-{1-[3-(5- methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol-3-yl} thiophene-2-carboxamide::US10577360, Example 149	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432285&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132035926	438641224							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877100	CN(C)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C27H30N6O3/c1-18-28-29-26(36-18)19-6-4-8-23(16-19)32-15-14-25(30-32)33(22-12-10-21(11-13-22)31(2)3)27(35)20-7-5-9-24(34)17-20/h4-9,14-17,21-22,34H,10-13H2,1-3H3/t21-,22-	VNSRUTZAHVRIKZ-HZCBDIJESA-N	432286	N-[(1r,4r)-4-(Dimethylamino)cyclohexyl]-3-hydroxy-N- {1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}benzamide::US10577360, Example 150	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432286&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132036106	438641225							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877101	CN(C)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C27H30N6O3/c1-18-28-29-26(36-18)19-6-4-8-23(16-19)32-15-14-25(30-32)33(22-12-10-21(11-13-22)31(2)3)27(35)20-7-5-9-24(34)17-20/h4-9,14-17,21-22,34H,10-13H2,1-3H3/t21-,22-	VNSRUTZAHVRIKZ-HZCBDIJESA-N	432286	N-[(1r,4r)-4-(Dimethylamino)cyclohexyl]-3-hydroxy-N- {1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}benzamide::US10577360, Example 150	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432286&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132036106	438641225							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877102	CN(Cc1ccccc1)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C31H32N6O2S/c1-22-32-33-30(39-22)24-10-6-11-27(20-24)36-18-17-29(34-36)37(31(38)28-12-7-19-40-28)26-15-13-25(14-16-26)35(2)21-23-8-4-3-5-9-23/h3-12,17-20,25-26H,13-16,21H2,1-2H3/t25-,26-	TUJUJVMMXOKQBW-DIVCQZSQSA-N	432287	N-{(1r,4r)-4-[Benzyl(methyl)amino]cyclohexyl}-N-{1- [3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}thiophene-2-carboxamide::US10577360, Example 151	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432287&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585072	438641226							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877103	CN(Cc1ccccc1)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C31H32N6O2S/c1-22-32-33-30(39-22)24-10-6-11-27(20-24)36-18-17-29(34-36)37(31(38)28-12-7-19-40-28)26-15-13-25(14-16-26)35(2)21-23-8-4-3-5-9-23/h3-12,17-20,25-26H,13-16,21H2,1-2H3/t25-,26-	TUJUJVMMXOKQBW-DIVCQZSQSA-N	432287	N-{(1r,4r)-4-[Benzyl(methyl)amino]cyclohexyl}-N-{1- [3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}thiophene-2-carboxamide::US10577360, Example 151	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432287&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585072	438641226							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877104	CN(Cc1ccccc1)[C@H]1CC[C@H](CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C31H32N6O2S/c1-22-32-33-30(39-22)24-10-6-11-27(20-24)36-18-17-29(34-36)37(31(38)28-12-7-19-40-28)26-15-13-25(14-16-26)35(2)21-23-8-4-3-5-9-23/h3-12,17-20,25-26H,13-16,21H2,1-2H3/t25-,26+	TUJUJVMMXOKQBW-WMPKNSHKSA-N	432288	N-{(1s,4s)-4-[Benzyl(methyl)amino]cyclohexyl}-N-{1- [3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}thiophene-2-carboxamide::US10577360, Example 152	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432288&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585072	438641227							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877105	CN(Cc1ccccc1)[C@H]1CC[C@H](CC1)N(C(=O)c1cccs1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C31H32N6O2S/c1-22-32-33-30(39-22)24-10-6-11-27(20-24)36-18-17-29(34-36)37(31(38)28-12-7-19-40-28)26-15-13-25(14-16-26)35(2)21-23-8-4-3-5-9-23/h3-12,17-20,25-26H,13-16,21H2,1-2H3/t25-,26+	TUJUJVMMXOKQBW-WMPKNSHKSA-N	432288	N-{(1s,4s)-4-[Benzyl(methyl)amino]cyclohexyl}-N-{1- [3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}thiophene-2-carboxamide::US10577360, Example 152	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432288&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585072	438641227							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877106	CN(Cc1ccccc1)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C33H34N6O3/c1-23-34-35-32(42-23)25-10-6-12-29(20-25)38-19-18-31(36-38)39(33(41)26-11-7-13-30(40)21-26)28-16-14-27(15-17-28)37(2)22-24-8-4-3-5-9-24/h3-13,18-21,27-28,40H,14-17,22H2,1-2H3/t27-,28-	QVXIKBDHBZZDCM-QVYRIUEQSA-N	432289	N-{(1r,4r)-4-[Benzyl(methyl)amino]cyclohexyl}-3-hydroxy- N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}benzamide::US10577360, Example 153	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432289&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585013	438641228							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877107	CN(Cc1ccccc1)[C@H]1CC[C@@H](CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C33H34N6O3/c1-23-34-35-32(42-23)25-10-6-12-29(20-25)38-19-18-31(36-38)39(33(41)26-11-7-13-30(40)21-26)28-16-14-27(15-17-28)37(2)22-24-8-4-3-5-9-24/h3-13,18-21,27-28,40H,14-17,22H2,1-2H3/t27-,28-	QVXIKBDHBZZDCM-QVYRIUEQSA-N	432289	N-{(1r,4r)-4-[Benzyl(methyl)amino]cyclohexyl}-3-hydroxy- N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 3-yl}benzamide::US10577360, Example 153	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432289&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585013	438641228							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877108	CN(Cc1ccccc1)[C@H]1CC[C@H](CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C33H34N6O3/c1-23-34-35-32(42-23)25-10-6-12-29(20-25)38-19-18-31(36-38)39(33(41)26-11-7-13-30(40)21-26)28-16-14-27(15-17-28)37(2)22-24-8-4-3-5-9-24/h3-13,18-21,27-28,40H,14-17,22H2,1-2H3/t27-,28+	QVXIKBDHBZZDCM-HNRBIFIRSA-N	432290	N-{(1s,4s)-4-[Benzyl(methyl)amino]cyclohexyl}-3-hydroxy- N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H- pyrazol-3-yl}benzamide::US10577360, Example 154	Mu-type opioid receptor	Homo sapiens	<100								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432290&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585013	438641229							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877109	CN(Cc1ccccc1)[C@H]1CC[C@H](CC1)N(C(=O)c1cccc(O)c1)c1ccn(n1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C33H34N6O3/c1-23-34-35-32(42-23)25-10-6-12-29(20-25)38-19-18-31(36-38)39(33(41)26-11-7-13-30(40)21-26)28-16-14-27(15-17-28)37(2)22-24-8-4-3-5-9-24/h3-13,18-21,27-28,40H,14-17,22H2,1-2H3/t27-,28+	QVXIKBDHBZZDCM-HNRBIFIRSA-N	432290	N-{(1s,4s)-4-[Benzyl(methyl)amino]cyclohexyl}-3-hydroxy- N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H- pyrazol-3-yl}benzamide::US10577360, Example 154	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432290&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585013	438641229							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877110	CN1CCC(CC1)N(C(=O)c1cccs1)c1cnn(c1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C23H24N6O2S/c1-16-25-26-22(31-16)17-5-3-6-19(13-17)28-15-20(14-24-28)29(18-8-10-27(2)11-9-18)23(30)21-7-4-12-32-21/h3-7,12-15,18H,8-11H2,1-2H3	NBGOUIQBRJPWCD-UHFFFAOYSA-N	432291	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 4-yl}-N-(1-methylpiperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 155	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432291&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010705	438641230							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877111	CN1CCC(CC1)N(C(=O)c1cccs1)c1cnn(c1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C23H24N6O2S/c1-16-25-26-22(31-16)17-5-3-6-19(13-17)28-15-20(14-24-28)29(18-8-10-27(2)11-9-18)23(30)21-7-4-12-32-21/h3-7,12-15,18H,8-11H2,1-2H3	NBGOUIQBRJPWCD-UHFFFAOYSA-N	432291	N-{1-[3-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-1H-pyrazol- 4-yl}-N-(1-methylpiperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 155	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432291&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010705	438641230							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877112	CN1CCC(CC1)N(C(=O)c1ccc(O)cc1)c1cnn(c1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H26N6O3/c1-17-27-28-24(34-17)19-4-3-5-21(14-19)30-16-22(15-26-30)31(20-10-12-29(2)13-11-20)25(33)18-6-8-23(32)9-7-18/h3-9,14-16,20,32H,10-13H2,1-2H3	QZPVIMGDMQMYDL-UHFFFAOYSA-N	432292	4-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-4-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 156	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432292&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585032	438641231							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877113	CN1CCC(CC1)N(C(=O)c1ccc(O)cc1)c1cnn(c1)-c1cccc(c1)-c1nnc(C)o1	InChI=1S/C25H26N6O3/c1-17-27-28-24(34-17)19-4-3-5-21(14-19)30-16-22(15-26-30)31(20-10-12-29(2)13-11-20)25(33)18-6-8-23(32)9-7-18/h3-9,14-16,20,32H,10-13H2,1-2H3	QZPVIMGDMQMYDL-UHFFFAOYSA-N	432292	4-Hydroxy-N-{1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]- 1H-pyrazol-4-yl}-N-(1-methylpiperidin-4-yl)benzamide::US10577360, Example 156	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432292&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585032	438641231							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877114	COc1cc(F)cc(c1)-n1cc(cn1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23FN4O2S/c1-24-7-5-16(6-8-24)26(21(27)20-4-3-9-29-20)18-13-23-25(14-18)17-10-15(22)11-19(12-17)28-2/h3-4,9-14,16H,5-8H2,1-2H3	INIPXJKHORSYIH-UHFFFAOYSA-N	432293	N-[1-(3-Fluoro-5-methoxyphenyl)-1H-pyrazol-4-yl]-N-(1- methylpiperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 157	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432293&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			138585190	438641232							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877115	COc1cc(F)cc(c1)-n1cc(cn1)N(C1CCN(C)CC1)C(=O)c1cccs1	InChI=1S/C21H23FN4O2S/c1-24-7-5-16(6-8-24)26(21(27)20-4-3-9-29-20)18-13-23-25(14-18)17-10-15(22)11-19(12-17)28-2/h3-4,9-14,16H,5-8H2,1-2H3	INIPXJKHORSYIH-UHFFFAOYSA-N	432293	N-[1-(3-Fluoro-5-methoxyphenyl)-1H-pyrazol-4-yl]-N-(1- methylpiperidin-4-yl)thiophene-2-carboxamide::US10577360, Example 157	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432293&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			138585190	438641232							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877116	Cc1nnc(o1)-c1cccc(c1)-n1cc(cn1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C28H27N7O2S/c1-20-31-32-26(37-20)22-8-5-9-24(16-22)34-19-25(17-30-34)35(28(36)27-29-12-15-38-27)23-10-13-33(14-11-23)18-21-6-3-2-4-7-21/h2-9,12,15-17,19,23H,10-11,13-14,18H2,1H3	TVMJTUZTGVXSKD-UHFFFAOYSA-N	432294	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4- oxadiazol-2-yl)phenyl]-1H-pyrazol-4-yl}thiazole-2- carboxamide::US10577360, Example 158	Mu-type opioid receptor	Homo sapiens	>500								US Patent		10.7270/Q2MC92DM		aid1804200	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432294&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search			132010422	438641233							1	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP	4DKL,8EF5,8EF6,8EFL,8EFO,8EFQ	Mu-type opioid receptor	OPRM_HUMAN	P35372	B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
877117	Cc1nnc(o1)-c1cccc(c1)-n1cc(cn1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1nccs1	InChI=1S/C28H27N7O2S/c1-20-31-32-26(37-20)22-8-5-9-24(16-22)34-19-25(17-30-34)35(28(36)27-29-12-15-38-27)23-10-13-33(14-11-23)18-21-6-3-2-4-7-21/h2-9,12,15-17,19,23H,10-11,13-14,18H2,1H3	TVMJTUZTGVXSKD-UHFFFAOYSA-N	432294	N-(1-Benzylpiperidin-4-yl)-N-{1-[3-(5-methyl-1,3,4- oxadiazol-2-yl)phenyl]-1H-pyrazol-4-yl}thiazole-2- carboxamide::US10577360, Example 158	Voltage-dependent calcium channel subunit alpha-2/delta-1	Human	>5000								US Patent		10.7270/Q2MC92DM		aid1804201	US10577360	Goya, P; Torrens-Jover, A; Almansa-Rosales, C; Diaz-Fernandez, J; Caamano-Moure, A	3/3/2020	11/20/2020	ESTEVE PHARMACEUTICALS, S.A.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=432294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10755&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=432294&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1&column=ki&startPg=0&Increment=50&submit=Search			132010422	438641233							1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL	7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM	Voltage-dependent calcium channel subunit alpha-2/delta-1	CA2D1_HUMAN	P54289	Q17R45 Q9UD80 Q9UD81 Q9UD82